Medicaid Program; Payment Adjustment for Provider-Preventable Conditions Including Health Care-Acquired Conditions, 32816-32838 [2011-13819]
Download as PDF
32816
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
42 CFR Parts 434, 438, and 447
[CMS–2400–F]
RIN 0938–AQ34
Medicaid Program; Payment
Adjustment for Provider-Preventable
Conditions Including Health CareAcquired Conditions
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final rule.
AGENCY:
This final rule will implement
section 2702 of the Patient Protection
and Affordable Care Act which directs
the Secretary of Health and Human
Services to issue Medicaid regulations
effective as of July 1, 2011 prohibiting
Federal payments to States under
section 1903 of the Social Security Act
for any amounts expended for providing
medical assistance for health careacquired conditions specified in the
regulation. It will also authorize States
to identify other provider-preventable
conditions for which Medicaid payment
will be prohibited.
DATES: These regulations are effective
on July 1, 2011.
FOR FURTHER INFORMATION CONTACT:
Venesa Day, (410) 786–8281, or Marsha
Lillie-Blanton, (410) 786–8856.
SUPPLEMENTARY INFORMATION:
SUMMARY:
mstockstill on DSK4VPTVN1PROD with RULES2
Acronyms
To assist the reader, the following list of
the acronyms are used in this final rule:
AHRQ Agency for Healthcare Research and
Quality
BPM Benefit Policy Manual
CABG Coronary artery bypass graft
CBO Congressional Budget Office
CDC Centers for Disease Control and
Prevention
DVT Deep vein thrombosis
ESRD End-stage renal disease
DRA Deficit Reduction Act of 2005 (Pub. L.
109–171, enacted on February 8, 2006)
FFP Federal financial participation
FY Fiscal year
HAC Hospital-acquired condition
HCAC Health care-acquired condition
ICR Information collection requirement
IH Inpatient Hospital
IPPS Inpatient prospective payment system
MS–DRG Diagnosis-related group
NCA National coverage analysis
NDC National coverage determination
NQF National Quality Forum
OACT [CMS] Office of the Actuary
OIG Office of Inspector General
OMB Office of Management and Budget
OPPC Other provider-preventable condition
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
PE Pulmonary embolism
POA Present on admission
PPC Provider-preventable condition
PRA Paperwork Reduction Act
RFA Regulatory Flexibility Act (September
19, 1980, Pub. L. 96–354)
RIA Regulatory impact analysis
SMDL State Medicaid Director Letter
SPA State plan amendment
UMRA Unfunded Mandates Reform Act of
1995 (Pub. L. 104–04, enacted on March
22, 1995)
UTI Urinary tract infection
from time-to-time find necessary to
assure the correctness and verification
of such reports. In addition, section
1902(a)(19) of the Act requires that a
State plan for medical assistance
provide such safeguards as may be
necessary to assure that eligibility for
care and services under the plan will be
determined, and such care and services
will be provided, in a manner consistent
with simplicity of administration and
the best interests of the recipients.
I. Background
Title XIX of the Social Security Act
(the Act) authorizes Federal grants to
the States for Medicaid programs to
provide medical assistance to persons
with limited income and resources.
While Medicaid programs are
administered by the States, they are
jointly financed by the Federal and State
governments. Each State establishes its
own eligibility standards, benefits
packages, payment rates, and program
administration for Medicaid in
accordance with Federal statutory and
regulatory requirements. Operating
within broad Federal parameters, States
select eligibility groups, types, and
range of services, payment levels for
services, and administrative and
operating procedures. Each State
Medicaid program must be described
and administered in accordance with a
Federally-approved ‘‘State plan.’’ This
comprehensive document describes the
nature and scope of the State’s Medicaid
program, and provides assurances that it
will be administered in conformity with
all Federal requirements.
The Federal government pays its
share of medical assistance
expenditures to the State on a quarterly
basis according to a formula described
in sections 1903 and 1905(b) of the Act.
Specifically, section 1903 of the Act
requires that the Secretary (except as
otherwise provided) pay to each State
which has a plan approved under title
XIX, for each quarter, an amount equal
to the Federal medical assistance
percentage of the total amount
expended during such quarter as
medical assistance under the State plan.
Among the statutory requirements for
Medicaid State plans, section 1902(a)(4)
of the Act requires that State plans
provide for methods of administration
as are found to be necessary by the
Secretary for the proper and efficient
operation of the plan. Section 1902(a)(6)
of the Act requires that a State plan for
medical assistance provide that the
State agency will make such reports, in
such form and containing such
information, as the Secretary may from
time-to-time require, and comply with
such provisions as the Secretary may
A. The Medicare Program and Quality
Improvements Made in the Deficit
Reduction Act of 2005 (DRA) (Pub. L.
109–171)
Title XVIII of the Act provides
authority for the Secretary to operate the
Medicare program, which provides
payment for certain medical expenses
for persons 65 years of age or older,
certain disabled individuals, and
persons with end-stage renal disease
(ESRD). Medicare benefits include
inpatient care, a wide range of medical
services, and outpatient prescription
drugs.
The Medicare statute authorizes the
Secretary, in the course of operating the
Medicare program, to develop,
implement, and monitor quality
measures, as well as take other actions,
to ensure the quality of the care and
services received by Medicare
beneficiaries.
Payment under the Medicare program
for inpatient hospital services is
generally based on the ‘‘inpatient
prospective payment system’’ (IPPS)
described in section 1886(d) of the Act.
Hospitals receive a payment for each
inpatient discharge based in part on
diagnosis codes that identify a
‘‘diagnosis-related group’’ (MS–DRG).
Assignment of an MS–DRG can take into
account the presence of secondary
diagnoses, and payment levels are also
adjusted to account for a number of
hospital-specific factors.
Section 5001(a) of the Deficit
Reduction Act of 2005 (Pub. L. 109–171,
enacted on February 8, 2006) (DRA)
amended section 1886(b)(3)(B) of the
Act to expand the set of hospital quality
measures collected by Medicare. In
particular, this provision directed the
Secretary to start collecting baseline
measures set forth by the Institute of
Medicine in its November 2005 report.
In FY 2008 and subsequent years, the
Secretary was required to add other
measures that reflect consensus among
affected parties. The provision also
allowed the Secretary to replace and
update existing quality measures. The
statute mandates that the Secretary
establish a process for hospitals to
review data that will be made public
PO 00000
Frm 00002
Fmt 4701
Sfmt 4700
E:\FR\FM\06JNR2.SGM
06JNR2
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES2
and, after that process is complete,
requires the Secretary to post measures
on the Hospital Compare Internet Web
site.
Section 5001(c) of the DRA amended
section 1886(d)(4) of the Act to adjust
payment to hospitals for certain
preventable hospital-acquired
conditions (HACs) identified by the
Secretary. Specifically, under section
1886(d)(4)(D)(iv) of the Act, the
Secretary is required to select codes
associated with at least two conditions
to be identified as HACs. These
conditions are required to have the
following characteristics: (a) High cost
or high volume or both; (b) result in the
assignment of a case to a MS–DRG that
has a higher payment when present as
a secondary diagnosis; and (c) could
reasonably have been prevented through
the application of evidence-based
guidelines. Section 5001(c) of the DRA
provides for revision of the list of
conditions from time to time, as long as
it contains at least two conditions.
B. Previously Specified Medicare HACs
Under the provisions of section
1886(d)(4)(D)(ii) of the Act, when a HAC
is not present on admission (POA), but
is reported as a secondary diagnosis
associated with the hospitalization, the
Medicare payment under IPPS to the
hospital may be reduced to reflect that
the condition was hospital-acquired.
More specifically, the hospital discharge
cannot be assigned to a higher paying
MS–DRG if the secondary diagnosis
associated with the HAC was the only
reason for this assignment.
Since October 1, 2007, hospitals
subject to the IPPS have been required
to submit information on Medicare
claims specifying whether diagnoses
were POA. The POA indicator reporting
requirement and the HAC payment
provision apply to IPPS hospitals only.
This requirement does not apply to
hospitals exempt from the IPPS.
The following is a list of the Medicare
HACs for FY 2011 (75 FR 50084 through
50085):
• Foreign Object Retained After
Surgery.
• Air Embolism.
• Blood Incompatibility.
• Stage III and IV Pressure Ulcers.
• Falls and Trauma.
+ Fractures.
+ Dislocations.
+ Intracranial Injuries.
+ Crushing Injuries.
+ Burns.
+ Electric Shock.
• Manifestations of Poor Glycemic
Control.
+ Diabetic Ketoacidosis.
+ Nonketotic Hyperosmolar Coma.
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
+ Hypoglycemic Coma.
+ Secondary Diabetes with
Ketoacidosis.
+ Secondary Diabetes with
Hyperosmolarity.
• Catheter-Associated Urinary Tract
Infection (UTI).
• Vascular Catheter-Associated
Infection.
• Surgical Site Infection Following:
+ Coronary Artery Bypass Graft
(CABG)—Mediastinitis.
+ Bariatric Surgery.
—Laparoscopic Gastric Bypass.
—Gastroenterostomy.
—Laparoscopic Gastric Restrictive
Surgery.
+ Orthopedic Procedures.
—Spine.
—Neck.
—Shoulder.
—Elbow.
• Deep Vein Thrombosis (DVT)/
Pulmonary Embolism (PE).
+ Total Knee Replacement.
+ Hip Replacement.
The Secretary may revise this list
upon review and does so through notice
and comment rulemaking.
C. Previously Specified Medicare
National Coverage Determinations
(NCD)
In 2002, the National Quality Forum
(NQF) published ‘‘Serious Reportable
Events in Healthcare: A Consensus
Report’’, which listed 27 adverse events
that were ‘‘serious, largely preventable
and of concern to both the public and
health care providers.’’ These events and
subsequent revisions to the list became
known as ‘‘never events.’’ This concept
and need for the proposed reporting led
to NQF’s ‘‘Consensus Standards
Maintenance Committee on Serious
Reportable Events,’’ which maintains
and updates the list which currently
contains 29 items.
The Medicare program has addressed
certain ‘‘never events’’ through national
coverage determinations (NCDs).
Similar to any other patient population,
Medicare beneficiaries may experience
serious injury and/or death if they
undergo erroneous surgical or other
invasive procedures and may require
additional healthcare to correct adverse
outcomes that may result from such
errors. To address and reduce the
occurrence of these surgeries, CMS
issued three NCDs. Under these NCDs,
CMS does not cover a particular surgical
or other invasive procedure to treat a
particular medical condition when the
practitioner erroneously performs: (1) A
different procedure altogether; (2) the
correct procedure but on the wrong
body part; or (3) the correct procedure
PO 00000
Frm 00003
Fmt 4701
Sfmt 4700
32817
but on the wrong patient. Medicare will
also not cover hospitalizations and other
services related to these non-covered
procedures.
D. Prior Guidance on Medicaid HACs
and NCDs in Response to Medicare’s
Policy
Section 5001(c) of the DRA addressed
only payment under the Medicare IPPS
and did not require that Medicaid
implement nonpayment policies for
HACs. However, in light of the Medicare
requirements, we encouraged States to
adopt payment prohibitions on provider
claims for HACs to coordinate with the
Medicare prohibitions under section
1886(d)(4)(D) of the Act. To accomplish
this task, we issued State Medicaid
Director Letter (SMDL) #08–004 on July
31, 2008. In the July 31, 2008 SMDL, we
noted that there was variation in how
State Medicaid programs had addressed
such claims in the past. The letter noted
that nearly 20 States already had, or
were considering, eliminating payment
for some or all of the 28 conditions on
the NQF’s list of Serious Reported
Events. Other States had more limited
efforts to deny payment for services
related to such conditions because the
services were ‘‘medically unnecessary’’
in light of the primary diagnosis.
Recognizing this variation and
addressing the immediate concern of the
States over Federal cost-shifting that
could result from the Medicare HAC
policy as applied to those who are
dually-eligible for Medicare and
Medicaid, we took a flexible position in
the July 31, 2008 SMDL guidance on
State Medicaid handling of the issue.
The SMDL indicated that States seeking
to implement HAC nonpayment policies
could do so by amending their Medicaid
State plans to specify the extent to
which they would deny payment for an
HAC. Those interested only in avoiding
secondary liability for Federal Medicare
denials of HACs and NCDs in the case
of dual-eligibles could do so by
amending their State Plan to indicate
that payment would not be available for
HACs and the procedures described in
the three NCDs that are not paid by
Medicare. States that wanted broader
payment prohibitions could indicate
that payment would not be available for
conditions specified in the State plan
amendment (SPA), or that meet criteria
identified in the SPA.
E. Section 2702 of the Affordable Care
Act
Section 2702 of the Affordable Care
Act requires that the Secretary
implement Medicaid payment
adjustments for health care-acquired
conditions (HCACs). Section 2702 of the
E:\FR\FM\06JNR2.SGM
06JNR2
mstockstill on DSK4VPTVN1PROD with RULES2
32818
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
Affordable Care Act did not grant the
Secretary new authorities, indicating
that existing statutory authorities are
sufficient to fulfill the obligation.
Section 2702(a) of the Affordable Care
Act sets out a general framework for
application of Medicare prohibitions on
payment for HCACs to the Medicaid
program. Section 2702(a) of the
Affordable Care Act first directs the
Secretary to identify current State
practices that prohibit payment for
HCACs and to incorporate the practices
identified, or elements of such practices,
which the Secretary determines
appropriate for application to the
Medicaid program in regulations.
Section 2702(a) of the Affordable Care
Act then requires that, effective as of
July 1, 2011, the Secretary prohibit
payments to States under section 1903
of the Act for any amounts expended for
providing medical assistance for HCACs
specified in regulations. Such
regulations must ensure that the
prohibition on payment for HCACs shall
not result in a loss of access to care or
services for Medicaid beneficiaries.
Section 2702(b) of the Affordable Care
Act defines the term ‘‘health careacquired condition’’ as ‘‘a medical
condition for which an individual was
diagnosed that could be identified by a
secondary diagnostic code described in
section 1886(d)(4)(D)(iv) of the Act.’’
Section 2702(c) of the Affordable Care
Act specifically requires that the
Secretary, in carrying out section 2702
of the Affordable Care Act, apply the
regulations issued under section
1886(d)(4)(D) of the Act relating to the
prohibition of payments based on the
presence of a secondary diagnosis code
specified by the Secretary in such
regulations, as appropriate for the
Medicaid program. The Secretary may
exclude certain conditions identified
under title XVIII of the Act for
nonpayment under title XIX of the Act
when the Secretary finds the inclusion
of such conditions to be inapplicable to
beneficiaries under title XIX of the Act.
We believe, and confirmed through
public comment, that incorporating
Medicare’s HACs in Medicaid’s policy
is inherently complex because of
population differences across programs.
We fully understand that the HACs
developed for Medicare’s population
will not directly apply to various
subsets of Medicaid’s population. While
we have established Medicare as a
baseline, we understand that States will,
through their payment policies,
appropriately address these differences.
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
F. Requirement To Review Existing State
Practices Prohibiting Nonpayment
Policies for HCACs
Section 2702 of the Affordable Care
Act requires that the Secretary identify
current State practices that prohibit
payment for HCACs and incorporate
those practices, as appropriate, into
Medicaid regulations.
To fulfill the statutory direction, we
reviewed existing SPAs originally
submitted in response to the July 31,
2008 SMDL (#08–004). We also
researched State HCAC-related
nonpayment policies that had been
implemented outside of Medicaid State
plans. We reviewed State quality
assurance programs, pay-forperformance programs, reporting
requirements and procedures, and
payment systems.
We reviewed various articles, reports,
summaries, and data bases pertaining to
States’ existing practices concerning
hospital and HCACs and infections. For
a list of the items considered, see the
February 17, 2011 proposed rule (76 FR
9283, 9286 through 9287).
We discussed internally within CMS,
as well as with interagency partners at
the Agency for Healthcare Research and
Quality (AHRQ) and the CDC to ensure
that the proposed regulations were
consistent with other regulations,
policies, and procedures currently in
existence surrounding this issue. We
also met with them to gain information
on areas where we could mirror existing
processes to eliminate undue burdens
on States or providers.
We issued a State survey to capture
data from all related payment policies
regardless of whether they were
implemented as a result of the July 31,
2008 SMDL or whether such practices
are currently detailed in the State plan.
We have received helpful information
from a few States through the survey
and have reviewed other information
that has been helpful in explaining
current State processes for making
payment adjustments for HCACs.
Subsequent to the publication of the
survey, we held all-State calls where we
answered questions in response to the
survey, had States with existing policies
talk about their experiences, and
listened to discussion regarding the
implementation of the HCAC policy.
We met with nongovernmental
partners including the NQF, the
National Academy for State Health
Policy, the National Association of
Children’s Hospitals, the Joint
Commission, and State Medicaid
Medical Directors. Most of these
organizations are primarily focused on
State program development and/or
PO 00000
Frm 00004
Fmt 4701
Sfmt 4700
quality issues. We reached out to them
to ensure that the proposed policies
were consistent with current industry
understanding of both State payment
and quality improvement goals. In our
discussions with these organizations,
we were able to discuss State
experiences on a broad, national level
that had been gained from working with
States. During these meetings, we
discussed a number of issues related to
the proposed rule and State concerns in
implementing this provision. For
instance, it was clear from many of our
discussions that States hoped to be able
to look to this provision to provide
additional definition regarding the types
of conditions to identify for
nonpayment, as well as to provide some
support in working with provider
communities to which these policies
would be applied.
G. Current State Practices Prohibiting
Payment for HACs, HCACs, and Other
Similar Events
We found that 29 States do not have
existing HCAC-related nonpayment
policies. Most of the 21 States that
currently have HCAC-related
nonpayment policies identify at least
Medicare’s HACs for nonpayment in
hospitals. However, it is important to
note that at least half of the existing
policies we reviewed exceeded
Medicare’s current HAC requirements
and policies, either in the conditions
identified, the systems used to indicate
the conditions, or the settings to which
the nonpayment policies applied. These
policies vary tremendously from State to
State in the authority used to enact the
policies, the terminology used, the
conditions identified, State’s utilization
of the current Medicare HAC list, the
service settings to which nonpayment
policies are applied, reporting
requirements, and the claims processing
of the nonpayment policies.
All of the States with HCAC-related
nonpayment policies have implemented
provisions that would protect the State
from dual-eligible liability either by
directly prohibiting payment for
Medicare crossover claims or by relying
on existing State plan authority to deny
payment for claims previously denied
by Medicare.
We found that 17 of the States
implemented Medicaid specific policies
that reduce payment for services
provided to Medicaid beneficiaries.
Most of the States implementing
Medicaid specific policies identify at
least Medicare’s current list of HACs,
and nearly half of those States defined
a list that was different from Medicare’s
current list of HACs for nonpayment.
E:\FR\FM\06JNR2.SGM
06JNR2
mstockstill on DSK4VPTVN1PROD with RULES2
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
Similar variation exists in States’ plan
language identifying Medicare’s NCD for
nonpayment ranging from mirroring
Medicare to completely breaking from
Medicare. We do note, however, that the
nature of the NQF serious reportable
events, like surgery on the wrong body
part, proper surgery wrong patient, and
wrong surgery, is so severe that States
were likely to have relied on State
coverage provisions and appropriate
care requirements to deny payment for
these events.
We also found that States use
different general terminology for HCACrelated nonpayment policies even
though many of the conditions
identified overlap, are from the same
sources, and do not generally vary in
medical definition from one list to the
other. For example, 3 States identify ‘‘air
embolism’’ as a condition for
nonpayment under its plans with the
condition understood to be consistently
defined for medical purposes. However,
one State includes air embolisms on its
list of ‘‘HACs’’; another includes the
same condition as a ‘‘Serious Adverse
Event’’; and the third includes it on a list
of ‘‘Medical Errors.’’
We also found that at least 7 of the
States with HCAC-related nonpayment
policies apply those policies to settings
other than the inpatient hospital setting
required by Medicare, including both
physicians and ambulatory surgical
centers.
Variation across States is not
surprising given the States have been
permitted broad flexibility in defining
their HCAC policies and programs.
However, we attribute some of the
variety on this issue to the wealth of
information and evidence-based
guidelines available to States, either
through their own experiences and
resources or through industry
researched and developed resources
related to health system quality. Data
gathered on the conditions identified,
reporting strategies, and implementation
guidelines indicate that States have
relied heavily on existing health system
quality improvement research to define
requirements while tailoring policies
appropriate to their own systems. In
addition, our research indicates that
States’ HCAC-related nonpayment
policies are mainly intended to drive
broader health system agendas to
promote quality outcomes. We believe
the use of evidence-based measures and
the push for health system quality are
an appropriate foundation for the
proposed regulation. We proposed to
implement Medicaid HCAC regulations
that would provide some consistency
across health care payers (Medicare and
Medicaid). At the same time, we also
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
proposed to accommodate State
flexibility to design individual HCAC
policies for nonpayment, quality-related
programs suitable for their own
Medicaid program and health
marketplace to the extent such policies
go beyond Federally-established
minimum standards. The July 31, 2008
SMDL (#08–004) instructed States to
submit SPAs to enact nonpayment
provisions. Thirteen States submitted
SPAs to include PPC related
nonpayment provisions in their
Medicaid State plans. Other States that
implemented these policies through
some other authority like State law or
administrative procedures will be
required to submit new SPAs for review
and work with CMS to ensure their
policies, effective July 1, 2011, are in
line with the final provisions of this
rule.
H. Provider Preventable Conditions
The final rule includes the umbrella
term, ‘‘Provider-Preventable Conditions
(PPC)’’ which is defined as two distinct
categories, Health Care-Acquired
Conditions (HCAC) and Other ProviderPreventable Conditions (OPPC).
Health Care Acquired Conditions:
• Apply to Medicaid inpatient
hospital settings; and
• Are defined as the full list of
Medicare’s HAC, with the exception of
Deep Vein Thrombosis/Pulmonary
Embolism following total knee
replacement or hip replacement in
pediatric and obstetric patients, as the
minimum requirements for States’ PPC
non-payment programs.
Other Provider-Preventable
Conditions include the following:
• Apply broadly to Medicaid
inpatient and outpatient health care
settings where these events may occur;
• Are defined to include at a
minimum, the three Medicare National
Coverage Determinations (surgery on the
wrong patient, wrong surgery on a
patient, and wrong site surgery);
• Would allow States to expand to
settings other than IH with CMS
approval by nature of identifying events
that occur in other settings; and
• Would allow States to expand the
conditions identified for non-payment
with CMS approval, based on criteria set
forth in the regulation.
The final rule requires that States
revise Medicaid plans to comply with
this provision and mandates that States
implement provider self reporting
through claims systems. The final rule
protects beneficiary access to care by
eliminating States’ ability to unduly
impact providers for the occurrence of
conditions identified. The final rule
requires that:
PO 00000
Frm 00005
Fmt 4701
Sfmt 4700
32819
• No reduction in payment for a
provider preventable condition will be
imposed on a provider when the
condition defined as a PPC for a
particular patient existed prior to the
initiation of treatment for that patient by
that provider.
• Reductions in provider payment
may be limited to the extent that the
identified provider-preventable
conditions would otherwise result in an
increase in payment; and the State can
reasonably isolate for nonpayment the
portion of the payment directly related
to treatment for, and related to, the
provider-preventable conditions.
While the Statutory effective date is
July 1, 2011, CMS intends to delay
compliance action on these provisions
until July 1, 2012.
We proposed to exercise our authority
under sections 1902(a)(4), 1902(a)(19),
and 1902(a)(30)(A) of the Act to provide
for identification of provider
preventable conditions (PPCs) as an
umbrella term for hospital and
nonhospital acquired conditions
identified by the State for nonpayment
to ensure the high quality of Medicaid
services. These statutory provisions
authorize requirements that States use
methods and procedures determined by
the Secretary to be necessary for the
proper and efficient administration of
the State plan, to provide care and
services in the best interests of
beneficiaries, and to provide for
payment that is consistent with quality
of care, efficiency, and economy.
With the introduction of this term, we
proposed to include two categories of
PPCs—HCACs and other providerpreventable conditions (OPPCs). HCACs
would apply as required under the
statute. OPPCs would be applicable to
other conditions that States identify and
have approved through their Medicaid
State plans.
The inclusion of the new terms, PPCs
and OPPCs, is consistent with the
implementation of a broader application
of this policy which allows us to
appropriately incorporate existing State
practices. The adoption of a new term
is necessary because the term, ‘‘health
care-acquired condition’’ is very
narrowly defined in the Statute and
does not provide for the inclusion of
conditions other than those identified as
HACs for Medicare, even excludes the
three Medicare NCDs. Additionally, the
Affordable Care Act definition of
HCACs only applies to the inpatient
hospital setting.
We considered a broader definition of
the term, ‘‘health care-acquired
conditions,’’ attempting to isolate the
idea of the actual condition from the
setting in which it occurred. Section
E:\FR\FM\06JNR2.SGM
06JNR2
32820
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES2
1886(d)(4)(D)(iv) of the Act applies
specifically to conditions applicable to
inpatient hospital patients and
reimbursed under the IPPS. We did look
to the Affordable Care Act in creating
the terms PPCs and OPPCs.
We did look to the Affordable Care
Act in creating the terms PPC and
OPPC. Section 3008(b) of the Affordable
Care Act, ‘‘Study And Report On
Expansion Of Healthcare Acquired
Conditions Policy To Other Providers,’’
requires that Medicare study the effects
of expanding its existing policy to other
providers. We adopted the ‘‘Other
Providers’’ term to remain consistent
with Medicare in the potential
expansion of its policy.
In looking to expand the overall
policy, we considered a number of other
terms but determined that many of them
like ‘‘adverse events’’ or ‘‘serious
reportable events’’ would generate
confusion because they had existing
industry definitions that did not
necessarily overlap with our policy
aims. We adopted the term ‘‘Provider
Preventable Condition’’ for use in
Medicaid because it appropriately
identified the scope of the conditions
and could act as a ‘‘catch-all.’’ Also, the
term had not been narrowly defined by
use in Medicare, Medicaid, or in the
industry at-large.
I. Reporting of Results
After researching State, industry, and
Federal information related to the
importance of reporting of quality data
in driving improved health outcomes,
we proposed that a simplified level of
reporting is essential to creating a
successful nonpayment policy both
from the payment and quality
perspectives. We believe that any
requirements for provider reporting
should provide a consistent format for
States to report State-specific measures;
require that providers report conditions
identified for nonpayment when they
occur regardless of a provider’s
intention to bill; and not cause undue
burden on States or providers.
Quality reporting related to PPCs
across States is inconsistent. There are
27 States that require reporting of either
hospital-acquired infections, conditions,
or some combination of both. Some of
those States require quality reporting
but have not implemented associated
HCAC-related nonpayment policies.
Others have HCAC-related nonpayment
policies, but have not implemented
quality reporting requirements.
Existing national quality reporting
formats do not support the collection of
data on HCACs and OPPCs for Medicaid
beneficiaries. Providers, mainly
hospitals, are subject to reporting
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
requirements in addition to those
imposed by States. For instance, most
hospitals report some quality measures
to CMS, the Joint Commission, or the
CDC. We considered requiring hospitals
to report to CMS or the National Health
Safety Network, but decided against this
because of concerns about the capacity
within these systems to accommodate
State specific reporting of varied
measures and the fact that this might
not be consistent with what most States
are currently requiring providers to
report.
HACs, HCACs, and related policies
represent liabilities for providers
beyond nonpayment provisions. In fact,
Medicare and the industry-at-large, have
experienced nonclaiming or nonbilling
on the part of providers seeking to
escape the liability that could come
with any type of notification of a
particular event or to avoid negative
health outcome indicators.
In consideration of our research, we
proposed a requirement that existing
claims systems be used as a platform for
provider self-reporting. We also
proposed to include reporting
provisions that would require provider
reporting in instances when there is no
associated bill. For instance, States
could employ the widely used POA
system in combination with including
edits in their Medicaid claims systems
that would indicate an associated claim
and flag it for medical review.
J. States’ Use of Payment Systems Other
Than MS–DRG
We also found that States’ payment
systems will dictate the manner in
which States are able to operationalize
PPCs related nonpayment policies. For
instance, some States reimburse using
MS–DRG or some other type of grouper
software to price claims. As with
Medicare, these States may use the POA
indicator system to identify claims and
reduce payments by programming the
grouper to reduce payment through the
grouper. We note that a considerable
number of States do not use grouper
systems to reimburse providers. These
States may identify and reduce payment
for HCACs using methods appropriate to
the specific reimbursement system used
within that State. We believe that the
proposed provision allows States this
type of flexibility in designing
methodologies that would isolate
amounts for nonpayment and allow
provider payment to be reduced based
on a CMS-approved State plan
methodology that is prospective in
nature.
PO 00000
Frm 00006
Fmt 4701
Sfmt 4700
II. Summary of the Provisions of the
Proposed Rule and Analysis of and
Responses to Public Comments
A. General Discussion
We proposed to codify provisions that
would allow States flexibility in
identifying PPCs that include, at a
minimum, the HACs identified by
Medicare, but may also include other
State-identified conditions. This
flexibility will extend to applying
nonpayment provisions to service
settings beyond the inpatient hospital
setting. We believe that establishing
Medicare as the minimum for the
application of this policy is appropriate
at this point.
We encouraged States to consider the
benefits and quality implications of
expanding HCAC quality and
nonpayment policies as more
information becomes available from
Medicare and State Medicaid programs.
We proposed that PPCs are defined
under two categories: HCACs and
OPPCs. We proposed to define the
category of PPCs that would be referred
to using the term ‘‘health care-acquired
conditions’’ (HCACs) based on the
definition of that term in section 2702(b)
of the Affordable Care Act. We also
noted that the Secretary has authority to
update the Medicare HAC list as
appropriate. As such, States are required
to comply with subsequent updates or
revisions in accordance with section
1886(d)(4)(D) of the Act.
We proposed to require that States
implement requirements for provider
self-reporting of HCACs in the Medicaid
claims payment process. We also
proposed to provide that States may
identify similar OPPCs related to
services furnished in settings other than
inpatient hospitals, which would also
be subject to a payment prohibition.
We further proposed that the
treatment of these OPPCs will be similar
to the treatment of HCACs. State plans
must provide for nonpayment for care
and services related to these OPPCs, and
Federal financial participation (FFP)
will not be available in State
expenditures for such care and services
related to OPPCs.
We received the following comments
in response to our general discussion.
1. General Comments
Comment: One commenter expressed
the view that the original Medicare HAC
policy adopted by CMS in FY 2008 for
hospitals subject to the Medicare
Inpatient Prospective Payment System
(IPPS hospitals), in response to the
requirements of the DRA, was flawed
policy and that many physicians
disagreed with the notion that some of
E:\FR\FM\06JNR2.SGM
06JNR2
mstockstill on DSK4VPTVN1PROD with RULES2
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
the identified Medicare HACs are
reasonably preventable. The commenter
was opposed to extending these
provisions to Medicaid and suggested
that CMS abandon the notion of a
nonpayment policy for HACs in both
Medicare and Medicaid and replace it
with a policy encouraging compliance
with evidence-based guidelines.
Response: We disagree. The Medicare
HAC payment policy was established
under the authority of section 5001(c) of
the DRA and has been in place since FY
2008. Section 2702 of the Affordable
Care Act requires that CMS adopt
similar regulations for the Medicaid
program taking into consideration
existing State practices and the
appropriate application to the Medicaid
program. This regulation, like the
Medicare HAC rule that preceded it,
was developed in direct response to the
enactment of that provision. While we
recognize that some of the PPCs are not
entirely preventable and should
therefore be excluded from the program.
However, most of these PPCs are never
events, which means they should never
happen, in the first place, and they are
entirely preventable if providers follow
best medical practices. This is true
regardless of whether a patient is a
senior citizen on Medicare or a child on
Medicaid. PPCs that used to be regarded
as not entirely preventable, like CLABSI
(or CAUTI), have been shown to be
preventable by providers. We believe
that the provisions of this rule will
provide a strong incentive for the
provider to apply best medical practice
and seek innovative methods to prevent
adverse outcomes. The HACs were
adopted by Medicare through an
evidence-based process. In addition, the
definition used for OPPC in new
§ 447.26 provides that States must
consider evidence-based guidelines in
adopting optional PPCs.
Comment: Some commenters
supported the policy of payment
adjustment when conditions were
demonstrated to be reasonably
preventable based on the evidence, but
thought that the population differences
between Medicare and Medicaid may
present distinct issues and
considerations in considering events for
nonpayment. Some commenters
questioned the appropriateness of the
application of Medicare HACs to
Medicaid populations, specifically
children and pregnant women.
Response: We agree that Medicare’s
population is generally different than
Medicaid’s and that those differences
may present distinct issues and
considerations. We realize that some
categories of Medicare’s HACs, like
Surgical Site Infection following CABG
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
or Bariatric surgery, are not typically
applicable to pediatric or obstetric
populations because the underlying
conditions associated with each of
Medicare’s HACs will not typically
occur in those populations, thus
limiting the frequency and relevance of
the HAC. We reviewed each of
Medicare’s HACs and the related
evidence-based prevention protocols to
determine whether the final rule should
specifically exclude any of the
conditions identified by Medicare, with
respect to populations more
characteristic of Medicaid, particularly
children and pregnant women. We
considered each in relation to the
following:
(1) Clinical applicability. That is, does
this condition occur in pediatric and
obstetric populations enough to
significantly impact the populations or
provider reimbursement?
(2) Availability of evidence based
guidelines appropriate to prevention for
the pediatric and obstetric populations.
Are there bundles specific to preventing
these conditions and infections in the
pediatric and obstetric populations? If
bundles do not exist, are there other
bundles that can be appropriately
applied to these populations?
(3) Reasonable preventability. Can the
conditions or infections be reasonably
prevented through the use of evidence
based guidelines to warrant financial
penalties? Our research determined that
certain Medicare HACs, such as Foreign
Objects Retained After Surgery, Air
Embolism, Blood Incompatibility, Stage
3 and 4 Pressure Ulcers, Falls and
Trauma, and Manifestations of Poor
Glycemic Control, Catheter Associated
Urinary Tract Infections, and VascularCatheter Associated Blood Stream
Infections, are clinically applicable to
all Medicaid populations, including
children and pregnant women. We
determined that there are evidencebased guidelines to support the
reasonable preventability of these
conditions in pediatric and obstetric
populations, and that there is no
indication that these prevention
guidelines would cause harm if
appropriately applied. There was no
evidence to indicate that a provider
adhering to these evidence based
guidelines could not reasonably
prevent, though not absolutely prevent
these infections in every case in
Medicaid populations.
Our research determined that Surgical
Site Infection following CABG, Bariatric
Surgery, or Orthopedic procedures is
not typically applicable to children and
pregnant women because it is not likely
that these populations would be subject
to some of the primary surgical
PO 00000
Frm 00007
Fmt 4701
Sfmt 4700
32821
procedures. However, we determined
that there are evidence-based guidelines
to support the reasonable preventability
of Surgical Site Infection following the
specified procedures when they do
occur in these populations.
Furthermore, there is no indication that
these prevention guidelines would
cause harm when appropriately applied.
There is no evidence to indicate that a
provider adhering to these evidence
based guidelines could not reasonably
prevent, though not absolutely prevent,
these infections in every case in
Medicaid populations.
Our research also determined that the
Medicare HAC Deep Vein Thrombosis/
Pulmonary Embolism (DVT/PE) as
related to a total knee replacement or
hip replacement is not a common
occurrence for children or pregnant
women because it is not likely that these
populations would be subject to the
primary surgical procedures of total
knee replacement or hip replacement.
We determined that evidence-based
guidelines available support the
reasonable preventability of DVT/PE in
most cases, however, the related
prevention protocols have not been
proven appropriate for application in
children and pregnant women.
Therefore, we are not identifying the
Medicare HAC, DVT/PE as related to
total knee replacement, or hip
replacement for pediatric or obstetric
populations under Medicaid’s PPC
policy. We have revised the final rule to
reflect this determination.
We remind commenters that the
Medicare HACs serve as a baseline, and
that States electing to expand their
policies to consider other conditions
associated with children and pediatric
quality measures may do so through the
SPA process. We encourage States to
collaborate both with CMS and other
States, as well as their provider
communities and stakeholders like CDC
and AHRQ to implement informed
policies appropriate to their Medicaid
populations. We will support State
efforts and cross-educate, through the
State plan amendment process and by
providing information that we gather
from States and other programs.
Comment: One commenter believed
that the expansion of PPCs for Medicaid
under the proposed rule goes beyond
any previous guidance shared by CMS
with the State during Affordable Care
Act-related conference calls.
Response: Discussions held with the
States, stakeholder groups and various
provider communities regarding this
policy were necessary to determine
existing State practices regarding nonpayment for health care-acquired
conditions. They were informational for
E:\FR\FM\06JNR2.SGM
06JNR2
32822
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES2
CMS and did not in any way commit the
Secretary to a particular policy
direction. They were also a first effort in
allowing States without existing policies
to gather some general information from
and network with States with existing
policies.
The final regulation incorporates
conditions identified as Medicare’s
HACs, with the exception of DVT/PE as
related to total knee replacement and
total hip replacement for pediatric and
obstetric populations, and 3 NCDs as the
minimum requirement for State PPC
nonpayment policies. The rule allows
States the flexibility, if desired, but does
not require, States to identify additional
conditions as PPCs under their
Medicaid programs. Additionally, States
have already begun to develop PPCrelated non-payment policies and this
rule would allow that work to continue.
Comment: A few commenters
believed that there was not sufficient
time to implement these provisions for
providers that had not already been
subject to Medicare’s policy, and were
particularly concerned with the
implementation timeframes for
reporting.
Response: We anticipate that States
and providers, especially those groups
of providers that have not been subject
to Medicare’s HAC policy, will need to
work collaboratively to develop policies
and implement reporting systems that
would complement existing payment
structures. We believe given the
timeframes involved and the need for
States to provide guidance to providers,
it would be appropriate to delay
compliance action on the provisions of
the rule until July 1, 2012.
Comment: One commenter requested
that we strike § 447.26(c)(4) because
they believed the access requirements
proposed there were already reflected in
447.204 which requires that payment be
sufficient to assure beneficiary access.
The commenter thought that any dual
interpretations could lead to
unwarranted litigation risks.
Response: We thank the commenter
for this comment. We have revised the
language at 447.26(c)(4) to clarify that,
‘‘A State plan must ensure that nonpayment for provider-preventable
conditions does not prevent access to
services for Medicaid beneficiaries.’’
2. Conditions Identified and Providers
Affected
Comment: Some commenters pointed
out that Medicare’s HAC policy applies
only to Medicare IPPS hospitals. These
commenters believed that CMS should
limit Medicaid PPC payment
restrictions to Medicaid participating
hospitals that are similar to Medicare
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
IPPS hospitals. Other commenters asked
for clarification on this same point.
Most of these commenters also believed
that we should limit States ability to
identify other PPCs, proposing that the
set of Medicare’s HACs and 3 NCDs be
used as a ceiling instead of as a floor for
Medicaid’s PPC policy.
Response: The Affordable Care Act
requires that HACs identified under the
Medicare IPPS are applicable to all
entities that operate as Medicaid
inpatient hospitals. We do not have the
authority to exempt any Medicaid
inpatient hospital providers from these
requirements. States currently have the
authority to extend PPC-related nonpayment policies to other conditions.
Comment: Some commenters objected
to the entire category of OPPC (affecting
providers other than hospitals) included
in the proposed regulation. Commenters
recommended that CMS consider and
impose a number of parameters related
to States’ implementation and selection
of the OPPC category.
Response: In preparing this
regulation, the Statute required that
CMS consider existing State practices
and determine whether, as a matter of
policy, it was appropriate to include
those established practices in these final
regulations. We determined that, in
some instances, States had implemented
provisions that applied to providers in
settings other than inpatient hospital
settings, including outpatient hospital
settings. We did not believe that it was
prudent to require of all States what had
been done in a few, but we wanted to
provide States the flexibility to do so.
Accordingly, we designed the PPC
provisions to allow the expansion of
State policies to other care settings, and
other conditions. In light of the
differences between the types of
participating providers and the enrollee
populations in Medicare and Medicaid,
we provided flexibility for States in the
identification and application of OPPCs.
We anticipate that States will consider
arguments made by particular providers
that these OPPCs should be defined so
that they do not apply to them. We
believe this is the appropriate forum for
consideration of the unique
circumstances of particular providers.
Comment: Some commenters
recommended that we consider the
benefits of and establish a nationally
consistent set of conditions identifiable
as PPCs for Medicaid.
Response: We determined that the
conditions identified as Medicare’s
HACs, with the exception of DVT/PE as
related to total knee replacement and
total hip replacement for pediatric and
obstetric populations, and 3 NCDs are
appropriate to serve as the baseline for
PO 00000
Frm 00008
Fmt 4701
Sfmt 4700
Medicaid’s PPC policy. We are strongly
committed to permitting State flexibility
to innovate in this area. State innovation
has been a significant driver of Federal
policy, and States have direct
experience with utilization and claims
review with respect to Medicaid
services.
Comment: Some commenters
suggested that the initial set of
conditions be more limited and targeted,
and that they be expanded
incrementally over time.
Response: Section 2702(b) of the
Affordable Care Act defines the term
‘‘health care-acquired condition’’ as ‘‘a
medical condition for which an
individual was diagnosed that could be
identified by a secondary diagnostic
code described in section
1886(d)(4)(D)(iv) of the Act.’’ The
provision also allows the Secretary to
exclude conditions not appropriate for
application in Medicaid. As such, the
final regulation incorporates conditions
identified as Medicare’s HACs, with the
exception of DVT/PE as related to total
knee replacement and total hip
replacement for pediatric and obstetric
populations, and 3 NCDs. Additionally,
we believe that the flexibility provided
States in developing additional PPCs,
beyond those established as the floor in
the final rule, allow for the type of
incremental expansion of this policy
that the commenters suggest.
Comment: Other commenters
recommended that Medicaid PPCs focus
on conditions specific to the Medicaid
population. A few commenters offered
that it would be ideal for CMS to
evaluate other Medicaid specific
conditions that would apply specifically
to pregnant women or children.
Response: We believe that the
flexibility provided States in the final
rule will facilitate the development of
additional Medicaid specific conditions
to be identified for nonpayment. Some
State Medicaid programs with existing
policies have identified conditions
specific to certain populations like
Obstetrical Hemorrhage with
Transfusion, which is a condition
specific to pregnant women. We
encourage States to follow CMS’s
example in identifying conditions by
working with provider communities and
industry partners.
Comment: A few commenters
suggested that CMS coordinate Federal
PPCs policies across agencies and with
other organizations developing quality
measures specific to Medicaid
populations.
Response: We are actively working to
coordinate with other health reform
initiatives such as the pediatric core
quality measures, accountable care
E:\FR\FM\06JNR2.SGM
06JNR2
mstockstill on DSK4VPTVN1PROD with RULES2
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
organizations, and health insurance
exchanges to develop coordinated
Federal policy in the area of Health
System Quality. We continue to
collaborate with States, providers, and
other stakeholders to inform policy
decisions related to this area.
Comment: Some commenters stated
that any extension of PPC beyond the
hospital setting was premature, and
emphasized that application of PPC to
other providers was not feasible because
of the different patient populations,
payment structures and conditions that
applied in different environments.
These commenters stated unique issues
in various provider settings including
long-term care settings, dialysis clinics,
and skilled nursing facilities.
Response: We disagree with the point
that the PPC provisions should be
limited to the hospital environment.
This rule requires that States adopt
minimum requirements for each
category of PPC. States have the
flexibility to identify additional OPPCs
if desired, but there is no requirement
to do so. Many States have already
identified conditions beyond the
minimum requirements in this final
rule. We understand clearly that the
category of OPPCs would allow
expansion beyond the hospital
environment and must be done in close
consultation with affected providers and
limited to situations where a State has
made a finding that the condition could
reasonably have been prevented in
ordinary cases. We have revised
regulatory text to make clear that these
are State determinations that must be
made based on State findings that the
condition is reasonably preventable
using procedures supported by
evidence-based guidelines. The
identification of PPCs in settings other
than the hospital setting makes sense
because, from the perspective of the
patient, it matters very little whether a
wrong site surgery occurred in a
hospital, an ambulatory surgery center,
or in a minor surgery done in the
physician’s office. Moreover, States
have already gone beyond the hospital
setting in their individual PPC policies.
All that this Federal regulation adds is
the HCAC category which requires
nonpayment for the full list of
Medicare’s HACs, with the exception of
Deep Vein Thrombosis/Pulmonary
Embolism following total knee
replacement or hip replacement in
pediatric and obstetric patients and the
OPPC category which requires the
minimum mandatory inclusion of what
are now the three Medicare NCDs:
Surgery on the wrong patient, wrong
surgery on a patient, and wrong site
surgery. We are simply replicating the
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
mandatory provisions in the Medicare
program, and adding these to the
existing State flexibility under Medicaid
to establish payment and quality
standards.
We encourage States to collaborate
both with CMS and other States, as well
as their provider communities and
stakeholders like CDC and AHRQ to
implement informed policies
appropriate to their Medicaid
populations. We will support State
efforts and cross-educate, through the
SPA process and by providing
information that we gather from States
and other programs.
Comment: A number of commenters
requested that CMS clarify that the
HCAC category applies only to inpatient
hospitals.
Response: This final rule has revised
regulatory language to clarify that the
HCAC category applies to all inpatient
hospital settings under Medicaid. The
OPPC category minimum requirements
(Medicare’s 3 NCDs) are applicable in
any healthcare service setting where
these events may occur.
Comment: One commenter expressed
concern that expansion of PPC to
nonhospital providers threatened the
access of Medicaid beneficiaries to care.
In particular, the commenter asked CMS
to clarify that Medicaid payment
disallowance for PPC would not apply
when the PPC was present at the time
the provider commenced treatment of
the patient.
Response: The language in the
proposed regulation was intended to
cover only situations where payment
reduction was being applied to
treatment for a condition not present on
admission or commencement of
treatment by that provider. However, we
understand that clarifying the language
of the regulation to emphasize this point
would be helpful and have done so in
this final regulation. New § 447.26 (c)(2)
explicitly states that ‘‘* * * no
reduction in payment for a PPC will be
imposed on a provider when the
condition defined as a PPC for a
particular patient existed prior to the
initiation of treatment for that patient by
that provider.’’ This was implied in the
previous language, but has now been
made explicit. CMS agrees with the
comment and is providing this
clarification.
CMS disagrees with the commenter’s
point that the expansion of State PPC
policies beyond the hospital
environment will limit access. We
understand clearly that expansion
beyond the hospital environment must
be done in close consultation with
affected providers and limited to
situations where a provider could
PO 00000
Frm 00009
Fmt 4701
Sfmt 4700
32823
reasonably have prevented the PPC.
However, from the perspective of the
patient, it matters very little whether a
wrong site surgery occurred in a
hospital, an ambulatory surgery center,
or in a minor surgery done in the
physician’s office. Moreover, as the
commenter notes, States have already
gone beyond the hospital setting in their
individual PPC policies.
Comment: One commenter requested
that CMS provide States additional
guidance on applying the Medicare
HAC criteria to Medicaid providers and
conditions. This commenter believed
that we should partner with States to
have continued dialogue on evidencebased guidelines.
Response: As stated throughout the
rule, we intend to continue dialogue
with States and other Agencies related
to this issue.
3. PPC Terminology
Comment: A few commenters
believed that the distinctions among the
terms in the proposed rule were
confusing and made it difficult to
understand which term applied to
which criteria.
Response: We have revised the
regulatory text to clarify that PPCs are
clearly defined into two separate
categories, HCACs (conditions
identified as Medicare’s HACs (with the
exception of DVT/PE following total
knee replacement or hip replacement in
pediatric and obstetric patients) for IPPS
purposes, applied broadly to Medicaid
inpatient hospitals) and OPPCs
(conditions applicable in any healthcare
service setting minimally defined as
Medicare’s 3 NCDs).
Comment: A few commenters
objected to the use of the term PPC. One
proposed the use of the alternative term
‘‘Preventable Healthcare Related
Conditions.’’ The commenters noted that
one proprietary organization is currently
utilizing the acronym PPC for
‘‘Potentially Preventable Conditions.’’
The commenters also questioned our
use of the term other provider
preventable condition and stated their
biggest concern was with creating a new
term that encompassed 3 NCDs so
closely related with the NQF’s ‘‘Serious
Reportable Events in Healthcare.’’ The
commenters recommended that CMS
not create explicit category titles under
the PPC umbrella term.
Response: As stated in the preamble,
the designation of these terms is
necessary to a policy that meets
statutory requirements in setting
Medicare’s policy as the minimum and
allowing States the flexibility to expand
beyond that minimum. We do not
believe that the term PPC has been
E:\FR\FM\06JNR2.SGM
06JNR2
mstockstill on DSK4VPTVN1PROD with RULES2
32824
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
narrowly defined across the industry to
include a specific set of policy
provisions as would be required by this
final rule. In addition, we do not believe
that the use of the PPC acronym will
infringe on any proprietary
organizations’ ability to continue to use
that acronym. We have not made any
revisions to this final rule to reflect this
comment.
Comment: One commenter had
questions regarding the definition of
OPPC. The commenter questioned
which evidence-based guidelines would
be used and recommended that the
regulation be expanded to include exact
definitions of the guidelines.
Response: It would be difficult to
determine a singular set of guidelines to
be identified for the various conditions
that States may identify under these
provisions. The rule provides States
flexibility in determining the conditions
identified for nonpayment under their
individual State plans. As States submit
plans for approval, we will evaluate the
conditions proposed by States and
determine their appropriateness for the
Medicaid program. Additionally, we
would remind commenters that the
Secretary has the authority to revisit
these provisions and may do so as this
policy area develops. We reject the
commenters recommendation and have
made no changes to the final provisions
regarding this issue.
Comment: Many commenters
recommended that more research be
done by Medicare and Medicaid on
applying PPC nonpayment policies to
outpatient settings before conditions
that occur in those settings are
incorporated into PPC nonpayment
policies or expanded. Some commenters
objected to the designation of the 3
NCDs as a baseline for the Medicaid
policy.
Response: Medicare is conducting
additional research to inform its policy
on applying its HAC provisions beyond
its IPPS hospitals. In preparing this
regulation, CMS was required to
consider existing State practices and
determine whether, as a matter of
policy, it was appropriate to include
those established practices in these final
regulations. We determined that, in
some instances, States had implemented
provisions that applied to providers in
settings other than inpatient hospital
settings, including outpatient hospital
settings. We did not believe that it was
prudent to require of all States what had
been done in a few, but we wanted to
provide States the flexibility to do so.
Accordingly, we designed the PPC
provisions to allow the expansion of
State policies to other care settings, and
other conditions. We agree that States
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
should do additional research to
evaluate the impact of applying
nonpayment policies in outpatient
settings before adopting such policies. It
should also be noted that States with
existing policies that do not meet the
minimum provisions of this final rule
and those without existing policies will
need to submit for CMS approval SPAs
implementing these policies.
The three events that we are requiring
that States include in their OPPC are
those events which already trigger
payment reductions in the Medicare
program as national coverage
determinations (NCDs). In the Medicare
program, NCDs are already applied to
all providers, not just to specified
hospitals. Medicare NCDs are detailed,
evidence-based determinations that are
supported by substantial data.
Therefore, inclusion of these three
events merely replicates evidence-based
determinations that are already in effect
in the Medicare program.
Comment: One commenter stated that
the expansion of State PPC policies into
non-inpatient settings will be extremely
difficult to implement due to the very
characteristics that are inherent to the
outpatient setting, such as: The types of
care and services provided; numerous
providers and provider-types involved
in care; periodic episodes of care
provided by numerous providers over
lengthy periods of time; and lack of
systems and infrastructure to adequately
coordinate care between visits and
providers, among others. The wide
variety of payment systems create
enormous challenges for provider
reporting, according to this commenter.
Response: We are encouraging States
to work with provider communities and
other stakeholders to carefully examine
nonpayment policies in non-inpatient
settings. Additionally, we are requiring
that States submit for approval
Medicaid State plan amendments that
would implement PPC nonpayment
policies. To support these Medicaid
State plan amendments, we are
clarifying that the State must have made
findings that the proposed PPC is
reasonably preventable through the
application of evidence-based
guidelines. The SPA review process will
give CMS and providers the opportunity
to consider State policy before it is
implemented and to provide guidance
and input based on our knowledge of
the issues.
4. POA and Coding Systems
Comment: Several commenters
objected to the burden of creating a POA
system and the potential for variation in
the different State PPC policies.
Commenters are concerned that the
PO 00000
Frm 00010
Fmt 4701
Sfmt 4700
POA requirement and its impact on
reimbursement may result in extraneous
testing, delayed care, and further access
issues for Medicaid patients. In
emergency situations, it is often
impossible to provide optimal patient
care and simultaneously determine POA
status, it was noted. One commenter
also noted that many hospitals were not
familiar with the intricacies of POA
coding and would require CMS
guidance and time to implement it.
Response: The POA system is not
required by this final regulation, but
obviously providers will need to
carefully document the physical status
of their patients on admission. That
documentation is not simply done for
legal purposes, but serves the legitimate
medical purpose of allowing for careful
evaluation the patient’s condition prior
to treatment and communicating that
information to members of the treatment
team. Ultimately, the provider will selfreport PPCs to the State. The State may
choose to verify this by a POA system
or by other methods.
Comment: One commenter disagreed
that relying on record review with the
‘‘Global Trigger Tool’’ to detect what is
present on admission will be effective in
detecting POA. The commenter
requested clarification on the method
and asserted that it is not CMS’s
responsibility to determine POA
retrospectively. The commenter opined
that since CMS is not the patient’s care
provider, this would be bureaucratic
over-reach into the patient-provider
relationship.
Response: We agree with the
commenter that it is not CMS’s
responsibility to determine the POA
status of a patient. The ‘‘Global Trigger
Tool’’ is a tool by which providers
would use a series of ‘‘triggers’’ to
determine the possible occurrence of an
adverse event and indicate further
review of a particular case. Neither the
proposed rule, nor this final rule
include any requirement that a provider
implement the use of the ‘‘Global Trigger
Tool.’’ We do suggest that our research
indicates that this tool may be useful in
identifying the occurrence of PPCs, as
well as others like nursing reviews or
concurrent utilization reviews.
Comment: One State commented that
the POA indicator is a very useful
resource to identify the specific hospital
where an adverse event occurred.
Response: We thank the commenter
for this information.
Comment: One commenter was
concerned with the use of the POA
indicator being applied to pediatric
populations because it may be hard to
determine whether a child entered an
emergency department with an
E:\FR\FM\06JNR2.SGM
06JNR2
mstockstill on DSK4VPTVN1PROD with RULES2
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
asymptomatic yet incubating infection.
This commenter recommended a study
be done to determine whether the
incubation period in a child is different
from an adult because the information
would influence the determination of
POA in certain cases.
Response: The POA system is not
required by this final regulation, but
obviously providers will need to
carefully document the physical status
of their patients on admission. That
documentation is not simply done for
legal purposes, but serves the legitimate
medical purpose of allowing for careful
evaluation the patient’s condition prior
to treatment and communicating that
information to members of the treatment
team. Ultimately, the provider will selfreport PPCs to the State. The State may
choose to verify this by a POA system
or by other methods.
In regard to the study of the
incubation period of infections in
children versus adults, the purpose of
this rule is to deny Medicaid payment
for PPCs. States will be required to
submit SPAs to implement these
policies, however, aside from the
minimum requirements in the rule
States have flexibility in determining
how to implement the related
provisions, including the conditions
identified for nonpayment. That being
said, we recognize the inherent
differences between the Medicare and
Medicaid populations and would note
that a major consideration for allowing
States such flexibility in the OPPC
category is the idea that States will be
able to work with their provider
communities and industry partners to
further consider the unique situation of
Medicaid beneficiaries within each
State. We realize that for children’s
hospitals and pediatric populations
there are a number of conditions that
could be otherwise identified. We
believe that States, working with their
provider communities, are in a better
position to develop additional
conditions specific to their Medicaid
populations and programs. We continue
to believe that innovations should be
shared across programs and States. As
information becomes available, we will
share implementation examples with
States. We also encourage States to
collaborate in this policy area.
Comment: One commenter
recommends that States consistently
adopt the ICD–9–CM and ICD–10–CM
codes as the only diagnostic standard
for identifying conditions for purposes
of Medicaid payment. According to this
commenter, it would be
administratively burdensome for
providers, as well as result in lack of
data comparability across Medicare and
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
Medicaid programs, to allow Medicaid
programs to use alternative coding
systems or their own method for
identifying each PPC.
Response: We agree that the ICD–9–
CM and ICD–10–CM codes present a
reasonable alternative to developing and
implementing unique diagnostic codes
for the purposes of this provision. We
encourage States to explore the use of
the ICD–9–CM and ICD–10–CM codes
for purposes of identifying PPCs under
their existing programs.
Comment: One commenter expressed
concern over identifying additional
costs associated with an adverse event
that occurs in a same day surgery center,
a skilled nursing facility or a clinic. The
commenter reported that it would be
very difficult to identify the clinic or
facility as the cause of the adverse event
because they are not reimbursed
through a DRG payment system. The
commenter notes that its claims system
would not isolate claim lines related to
the adverse event to distinguish them
from appropriate services.
Response: We appreciate the
response. We understand the difficulty
that States may face in applying this
policy in settings other than inpatient
hospital settings, but note that some
States have managed to apply these
policies quite broadly and successful
quality outcomes have resulted. We
encourage States to evaluate their
populations and work with their
provider communities to explore the
possibilities of expanding PPC policies
to non-inpatient hospital settings to
support States efforts to improve the
quality of care in their overall health
systems.
Comment: One State with hospitals
exempt from Medicare IPPS payment
under 1814(b)(3) of the Act noted that
its existing PPC policy, which started in
2008, has resulted in a 12 percent
decrease in measured hospital
complication rates with associated cost
reductions of $62 million which were
subsequently redistributed within
hospitals in that State. The State praised
CMS for allowing State flexibility in
developing PPC policy and outlined
planned State initiatives in reducing
preventable readmissions. This State
also noted that since its policy is
considerably expansive, it should be
exempted from this final rule.
Response: We do not have legal
authority to exempt any State from the
statutorily required provisions. We
disagree with the suggestion that a
States existing policy should exempt a
State from the requirements of this final
rule. The provisions of the final rule are
drafted to allow States flexibility in
developing individual PPC policies,
PO 00000
Frm 00011
Fmt 4701
Sfmt 4700
32825
while adhering to the minimum
requirements set forth. While we
appreciate the innovative nature of State
programs, we believe that it is necessary
for all States to appropriately amend
their Medicaid State plans to comply
with Federal law. This will also enable
other States to learn and be better
informed.
We also believe that this comment
illustrates the value of the Federal-State
partnership in Medicaid. Many of the
ideas used in this regulation were
originally developed by State Medicaid
programs interested in improving the
quality of care received by their
Medicaid beneficiaries. States, like other
stakeholders in the Medicaid system,
share a common interest in the
development of safe, efficient Medicaid
systems which serve their beneficiaries.
A common goal for CMS, States,
providers and patients is the pursuit of
better outcomes for individuals and
populations, while reducing
unsustainable costs through improved
quality of care. The pursuit of this
common goal strengthens not only
Medicaid, but the entire American
health care system.
Comment: Some commenters were
strongly supportive of the approach
taken by the proposed regulation. The
commenters endorsed the use of the
Medicare HAC as Medicaid HCAC and
the provision of flexibility to States
through the SPA process. In particular,
one group favored the preservation of
State ability to define PPC which
occurred outside of hospitals and the
three federally required OPPC. This
commenter stressed the value of
required State reporting systems and
suggested public posting of such data
after appropriate risk-adjustment and
data validation. The comment also
noted the importance of CMS
monitoring to assure that the PPC policy
had no adverse effects on beneficiary
access to care.
Response: We appreciate the
commenters’ support. We will monitor
the implementation of the final rule to
assure that beneficiary access to care is
not impaired.
5. General Comments
Comment: One commenter believes
that the proposed rule is inconsistent
because it states that hospitals will need
additional infection control staff to
prevent or reduce PPCs and that
hospitals already have programs in
place. The commenter also asks for
clarification on whether the
implementation cost estimates are
academic or provided by hospitals.
Response: The commenter is taking
these two points out of context. In the
E:\FR\FM\06JNR2.SGM
06JNR2
mstockstill on DSK4VPTVN1PROD with RULES2
32826
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
preamble to the proposed rule in
discussing options considered for
reporting requirements we say, ‘‘We
considered requiring reporting to
Hospital Compare and the National
Health Safety Network, but decided
against these formats because: We do
not believe they currently have the
capacity to allow State specific
reporting of varied measures; their
existing collections may not be
consistent with what most States are
currently requiring providers report;
and the reporting formats may impose
undue significant burden for
providers—particularly those that do
not have full-time quality staffs or
resources.’’ Later in the proposed rule
where we discuss the regulatory impact
analysis we state, ‘‘The Joint
Commission requires hospitals to have
established programs for Quality
Improvement, Risk Management, Safety,
and Infection Control. As a result, a
majority of hospitals already have in
place programs to avert Medicare HACs
and thus would not incur new costs to
implement parallel programs to avert
Medicaid HACs.’’ There are hospitals
that have existing programs. There are
also hospitals that will need to use
additional resources to meet State
requirements. This will be determined
by each individual hospital depending
upon its existing resources. The
estimates are based on our experience
with the implementation of like
provisions through the SPA process, as
well as Medicare’s experience
implementing its HAC policy.
Comment: Commenters were
concerned that States would be too
expansive in defining outpatient PPCs
and noted that, in the outpatient area,
there is limited provider control and
patient compliance issues are essential.
Another commenter expressed
concern that the provisions would allow
States to identify conditions not based
on accepted medical standards. It noted
that, in its State, the automated
Medicaid claims system used by
Medicaid health plans had limited
ability to report out or adjust for PPCs.
The commenter was critical of the short
timeline for compliance and expressed
concern that, in the dual eligible
category, there was a possibility of
double payment reduction.
Response: We note that an OPPC must
be supported by a finding by the State
that it ‘‘could have reasonably been
prevented through the application of
evidence-based guidelines.’’ To address
this comment, we have strengthened
this language to require that the finding
be based on a review of medical
literature by qualified professionals. As
a result, States PPCs will not be able to
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
identify a PPC without a strong basis to
do so, and we do not anticipate great
variation between States over time.
We are requiring that the providers
self-report PPCs, at which time the
health plan or State can, upon receipt of
the self-report, make an appropriate
payment correction. We believe that,
once providers have put in place
systems to track and report PPCs, they
will be able to use this information to
reasonably reduce the incidence of these
defined events in their facilities. For
dual eligibles, the intent of this rule is
that no payment would be available
under either Medicare’s IPPS or
Medicaid for an identified HAC. We do
not view this as a ‘‘double payment
reduction’’ but as a consistent
nonpayment policy. State Medicaid
agencies have repeatedly expressed to
CMS their concern that, with dual
eligibles, the impact of a Medicare HAC
denial was often that the provider
would simply bill Medicaid as a
secondary payer. This would result in
no denial of payment even when a
Medicare HAC occurred. Indeed, that
complaint from State Medicaid agencies
is one of the reasons that, in this
regulation, we are attempting to
coordinate Medicare and Medicaid
policies.
Comment: Several commenters
suggested that we develop a set of
standard definitions that account for
provider setting and other evidencebased factors that can be applied across
health care settings and across State
lines. Some also suggested that we
remove the option providing States the
ability to include any HCACs or OPPCs
beyond those required by Medicare to
encourage State-to-State uniformity.
Response: Medicaid is a Stateadministered program. By setting
Medicare’s hospital IPPS HAC policy as
the base policy, we are encouraging
uniformity across the two programs
while simultaneously allowing States to
retain the flexibility that is statutorilyafforded to them under title XIX of the
Act.
Comment: One commenter questioned
what would prevent hospitals from
spreading the cost of nonpayment for
PPCs out among all health care
consumers. The commenter suggested
that CMS institute an incentive system
by implementing a pre-paid provider
incentive pool rather than a
nonpayment system.
Response: The purpose of this
regulation is to establish rules that
would prevent Medicaid from paying
for HCACs resulting from provider error
and to encourage quality-based
reimbursement. Hospitals will continue
to be paid for the services provided. If
PO 00000
Frm 00012
Fmt 4701
Sfmt 4700
a patient enters the facility for a surgical
procedure and in the process of that
procedure a HCAC occurs, the hospital
will receive payment for the initial
surgical procedure but will not receive
payment for services provided in
addressing the HCAC. That being said,
this final rule sets out broad parameters
for allowing States to design PPC
policies that complement their current
systems. If a State is able to develop a
system that complies with the
requirements of this final rule through
an incentive based program, we
welcome the opportunity to review it as
part of a SPA and share it with other
States as appropriate.
Comment: Some commenters asked
CMS to provide in the final rules
specific guidance to States regarding the
inclusion of additional preventable
conditions; for example, issue specific,
evidence-based parameters for defining
‘‘preventable’’ with consideration for
issues like patient noncompliance.
Other commenters provided specific
conditions that they did not believe
States should identify for nonpayment
in their PPC policies. The commenters
had various reasons for objecting to
States’ inclusion of these conditions
based on patient population, facility
type, and administrative burden.
Response: The final rule does not
require that States include other
provider preventable conditions, but
provides States with the option to do so.
By allowing States to develop these
programs through State plan
amendments with the participation of
the provider community, we believe
that concerns such as this will be
addressed at the State level.
Comment: One commenter highlights
the fact the PPCs program’s impact on
States includes the administrative and
financial burden of building and
maintaining data collection systems, not
to mention the reality that State
Medicaid programs are run by public
administrators who may not have
training or experience in clinical issues,
comparative effectiveness research, and
other factors that are critical when
making payment restriction decisions.
Response: We agree that States may
need to employ additional resources to
implement a PPC policy, just as with
any other payment policy implemented
by States. The minimum requirements
under this final rule are designed to
minimize the administrative burden on
all stakeholders. The PPC policy is
designed to use existing data systems to
identify conditions as they occur. We
encourage States and providers to work
together to craft comprehensive PPC
nonpayment and reporting policies that
are reasonable and effective.
E:\FR\FM\06JNR2.SGM
06JNR2
mstockstill on DSK4VPTVN1PROD with RULES2
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
Comment: One commenter noted that
payment reductions for those hospitals
that have a high burden of Medicaid and
Medicare patients will challenge their
ability to stay open at current capacity
if they suffer significant payment
reductions due to the new rule. Critical
access hospitals may be the most
vulnerable due to the lack of
infrastructure to analyze their own data
and develop corrective actions prior to
the actual payment reductions,
according to the commenter.
Response: Hospitals will continue to
be paid for the provision of high quality
care under the final rule. The Affordable
Care Act requires that HACs identified
under Medicare IPPS rules are
applicable to all entities that operate as
Medicaid inpatient hospitals. We do not
have the authority to exempt any
Medicaid inpatient hospital providers
from these requirements.
Comment: One commenter noted that
under Medicare, the cost savings seems
relatively low as it pertains to all of the
HACs, which is the baseline for this
policy under Medicaid. According to
this commenter, there is very little data
to suggest that the savings under
Medicaid would be greater even if the
OPPCs are included. The commenter
recommend that CMS take a slower
approach to broadening the HCAC
policy by expanding from the Medicare
HACs over a longer period of time to
evaluate the savings from nonpayment
for HCACs under the Medicaid program.
Response: The purpose of this
regulation is to drive quality care, it is
not a cost savings exercise. We
recognize there may be some cost
savings and that it may take some time
to realize the full extent of the cost
savings, but this measure is important
for the long-term benefit of the Medicaid
program, Medicaid beneficiaries, and
the health care industry as a whole. We
intend for these provisions to be a
catalyst for change where the
infrastructure for quality measurement,
as well as the methods for improvement
that should be built into our system, are
not currently in place.
Comment: One commenter wrote to
share its success in quality
improvement within a particular State.
The commenter reported various
collaborations that it has undertaken
with its State and other stakeholder
organizations resulting in delivery
system innovations have proven
valuable and efficient.
Response: We appreciate this
comment and commend the commenter
for taking the necessary steps to
improve care to its beneficiaries. We
encourage other States and
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
organizations to innovate in the same
way.
Comment: One commenter
recommended that national clinical
consensus should be a component of the
criterion as to whether a condition is
‘‘reasonably preventable.’’
Response: We agree that a finding as
to whether a condition is ‘‘reasonably
preventable.’’ must be based on a solid
basis in national medical literature, as
determined by qualified professionals.
Therefore, we are retaining and
strengthening the portion of the OPPC
definition from the proposed rule that
requires that conditions identified by
States must be supported by a finding
that the conditions, ‘‘could have
reasonably been prevented through
evidence-based guidelines.’’ We are
adding that this State finding must be
based upon a review of medical
literature by qualified professionals. We
believe that this stronger language will
ensure a level of integrity and
consistency in these determinations.
Comment: One commenter believed
that Medicare has determined and will
continue to determine, with the help of
evidence-based guidelines, what is
reasonably preventable and what are
‘‘never events,’’ and that this should be
the standard across all regions of the
country because there would not be any
benefit to the population of beneficiaries
for one state to have different quality
health standards including for payment
consideration.
Response: The work that Medicare
has done in the process of developing
its IPPS HAC policy is valuable and
consistent. Adopting this work on a
national level will benefit States and
beneficiaries. This is part of the reason
the final regulation incorporates
conditions identified as Medicare’s
HACs, with the exception of DVT/PE as
related to total knee replacement and
total hip replacement for pediatric and
obstetric populations, and 3 NCDs as the
foundation of the Medicaid policy to be
applied in States.
Comment: One commenter believed,
in regard to flexibility as to the grouper
that each State selects to use to process
HCAC, that to achieve consistency there
needs to be limits placed on the choice.
Also, States need to be using the current
HIPAA administrative code set versions
that Medicare uses. This commenter
also supported the standardization of
public domain groupers to help reduce
the cost to healthcare providers and
States.
Response: States have great flexibility
in designing their own payment systems
and working with their provider
communities in determining how best to
implement these provisions. We do not
PO 00000
Frm 00013
Fmt 4701
Sfmt 4700
32827
intend to restrict that flexibility with
this final rule. We note that not all
States reimburse providers using
grouper methodologies. In regard to the
adoption of the standardization of
public domain groupers, we appreciate
this comment, but it is outside the scope
of this rule.
Comment: Many commenters
recommended that we revise Medicare’s
HAC list to include or eliminate various
conditions.
Response: We thank the commenters
for their input. However, revisions to
Medicare’s IPPS HAC list are outside
the scope of this rule.
Comment: Some commenters wrote
requesting clarification of or on the
application of Medicare’s HAC list.
Response: The commenters’ requests
are outside the scope of this rule. We
refer the commenter to the Medicare
HAC page located at https://
www.cms.gov/HospitalAcqCond/02_
Statute_Regulations_Program_
Instructions.asp#TopOfPage.
6. State Plan Amendments
Comment: One State noted that the
preamble (see 76 FR 9289) proposes that
States would be required to amend their
Medicaid State plans to match any
changes to Medicare’s final IPPS rule
that Medicare publishes 60 days prior to
the beginning of the next Federal fiscal
year. The State commented that 60 days
does not allow enough time to identify
ways to capture the data and program
and test changes to the payment system.
The State suggested that CMS clarify
that a State could comply by the
submission of a State plan amendment
by the end of the Federal quarter in
which the change takes effect, that is, by
the end of the first quarter of the next
Federal fiscal year.
Response: The Medicaid SPA process
requires that States submit amendments
to their Medicaid plans no later than the
last day of the quarter in which the
amendment would take effect. We have
developed a State plan preprint that
outlines the minimum provisions of this
final rule and allows States the
flexibility to identify OPPCs for
nonpayment in their Medicaid State
plans. States will define the related
payment methodologies within the
appropriate sections of their Medicaid
State plans.
7. Reporting Requirements
Comment: One commenter
recommended that reporting
requirements be included in States’
provider policies and included in
provider contracts.
Response: As discussed in the
proposed rule, a reporting component is
E:\FR\FM\06JNR2.SGM
06JNR2
mstockstill on DSK4VPTVN1PROD with RULES2
32828
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
essential to building an effective PPCs
policy for a number of reasons,
including State and CMS ability to
capture data related to these
occurrences. We believe that States will
need to work with their provider
communities to implement an
appropriate reporting system.
Comment: One commenter supports
the requirement that existing claims
systems be used as a platform for
provider self-reporting because it is
essential that their nonpayment policies
are based on data provided through
their claims systems.
Response: We thank the commenter
for support on this issue.
Comment: One commenter remarked
that provider self-reporting procedures
should require providers to report
conditions identified for nonpayment
when they occur, regardless of the
provider’s intention to bill. Hospitals
and providers have a clear incentive not
to report quality errors beyond
nonpayment provisions, according to
the commenter. CMS must take a strong
stance against underreporting and apply
strict penalties. Another commenter
requested that CMS clarify that States
would be required to submit provider
self-reporting data to CMS.
Response: In Medicaid, States are
given a large degree of flexibility under
title XIX of the Act. As such, providers
submit Medicaid claims to States and
not CMS. While we are requiring that
States implement self-reporting
requirements, States have the ability
under the statute to determine how they
will implement these requirements with
input from the provider communities.
Once data is collected at the State level,
States will submit that data to CMS as
part of their standard procedure for
collecting and sharing Medicaid
provider claims data.
Comment: Several commenters
supported provisions in the proposed
rule that would require States to
implement provider self-reporting
requirements through the claims
submission processes.
Response: We agree and have retained
these provisions in the final rule.
Comment: A few commenters believe
that providers will be over burdened
with the reporting requirements under
this new regulation. Additionally, they
disagreed with how long it would take
States to develop and implement
reporting requirements.
Response: The provisions of this final
rule require reporting through State
claims systems because they are existing
resources that are routinely and
regularly modified to accept State
payment adjustments for other
provisions. Most providers subject to
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
the minimum requirements of the final
provisions will be familiar with when
and how to report these conditions. In
States with existing policies, there are
already these types of reporting
requirements for payment purposes.
And, States electing to go beyond the
minimum requirements of these
provisions will need to work with their
provider communities to ensure that all
aspects of the provisions can be
sufficiently implemented. Provider
reporting is necessary to ensure that the
payment preclusion is effective in
eliminating PPCs, or determine whether
additional measures may be required, or
whether the measures applied are
necessary.
Comment: One commenter requested
clarification on the purpose of provider
reporting and how CMS expects States
to use reported information. Another
commenter noted that there is no clear
provision on how States are to report
this data to CMS. One State asks
whether the SPA will have to specify
how the reporting will be done, or if
States will need to assure that they will
comply with the requirement.
Response: We are requiring that States
impose provider self-reporting through
claims systems because that information
will be used to determine when a PPC
occurred and trigger State payment
action. The data will also be fed by
States to CMS. CMS and States will use
this data to inform policy making.
Comment: One commenter noted that
the proposed rule requires States to
establish a provider reporting
requirement for PPCs. The commenter
asked what the parameters will be for
those guidelines and how much latitude
CMS will give to the States.
Response: As a requirement of the
final rule, States will implement the
provider self-reporting through payment
claims systems regardless of the
provider’s intention to bill. We are
working to ensure that States
consistently report at least the minimum
requirements of the rule through the
Medicaid Management Information
Systems (MMIS). We anticipate that
States and providers, especially those
groups of providers that have not been
subject to Medicare’s HAC policy, will
need to work cooperatively to develop
and implement reporting systems that
would complement existing payment
structures. As discussed in the proposed
rule, a reporting component is essential
to building an effective PPCs policy for
a number of reasons, including State
and CMS ability to capture data related
to these occurrences.
PO 00000
Frm 00014
Fmt 4701
Sfmt 4700
8. Medicare and Medicaid Dual Eligibles
Comment: One commenter supports
nonpayment for all PPCs as they pertain
to the dual eligible population. This
commenter urges CMS to codify
provisions that prohibit Medicaid claim
payment for claims that have been
denied by Medicare based on the
presence of a HAC.
Response: We agree. This is a
significant area of concern, and we have
revised the final regulation to reflect
that no FFP is available for a Medicare
denied claim based on the presence of
a HAC, ‘‘A State plan must provide that
no medical assistance will be paid for
‘provider-preventable conditions’ as
defined in this section; and as
applicable for individuals dually
eligible for both the Medicare and
Medicaid programs.’’
Comment: Some commenters
requested clarification on how these
provisions would apply to Medicare
cross over claims. Commenters wanted
clarification on how to determine that
Medicare has rejected a HAC claim for
an individual dually eligible for
Medicare and Medicaid.
Response: We agree that the proposed
provisions lacked clarity in the
application to individuals dually
eligible for Medicare and Medicaid. We
have revised the final rule to provide
clarification. States may determine that
Medicare has reduced payment based
on the provisions of its HAC policy by
working with their Medicare Fiscal
Intermediary to identify the appropriate
codes related to treatment for dually
eligible individuals. Reference materials
regarding POA coding for Medicare
HACs may be found at https://
www.cms.gov/HospitalAcqCond/
05_Coding.asp#TopOfPage
To support State efforts, we will work
with the Federal Coordinated Health
Care Office to provide guidance on this
issue.
9. Managed Care
Comment: One commenter wrote in
support of the provision requiring States
to modify their managed care contracts
to reflect the PPCs payment adjustment.
Response: We agree and are retaining
requirements that States include PPC
payment restrictions in managed care
contracts. All providers should be held
to these quality standards and the final
rule retains these requirements.
Comment: One commenter requested
clarification of the expectation for
MCOs to refund money derived from the
nonpayment of PPCs back to States.
Response: We anticipate that savings
gained from the application of State PPC
policies to their managed care providers
E:\FR\FM\06JNR2.SGM
06JNR2
mstockstill on DSK4VPTVN1PROD with RULES2
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
will, ultimately, be factored into the
individual contract rates established
with those providers.
Comment: One commenter requested
clarification that the amendments to
§ 434.6 do not apply to MCOs, and
further, that the MCO contracts with
providers will not have to require
providers to report PPCs associated with
claims to the MCOs.
Response: On its own, the provisions
of § 434.6 do not apply to MCOs;
however, by cross-reference, we are
applying the specific provision in
§ 434.6(a)(12) regarding PPCs to MCO
contracts. We do intend that MCO
contracts with providers, identical to
Medicaid State agency’s contracts with
providers, require those providers to
report PPCs associated with claims to
the MCO. Further, so that the Medicaid
State agency will be able to quantify and
report, if necessary, information on all
PPCs in the Medicaid program, we
expect that MCOs will track PPC data
and make it available to the State upon
request. Accordingly, we are modifying
the proposed § 438.6 to clarify both
intentions.
Comment: A few commenters
requested that CMS provide guidance
for States on how to apply the
nonpayment requirement for HCACs to
capitation payments, specifically those
under § 438.6. Additionally, the
commenters requested information on
how these policies would apply to the
development of actuarially sound rates.
Response: We believe that the
implementation of State PPCs policies
will be consistent with what we
anticipate in the fee-for-service setting
and have only minimal impact on
provider payment and therefore the
development of actuarially sound rates.
However, as the MCOs spend less
money on services, that decrease will be
reported to the State which will in
future rate-setting reflect the reduced
expenditures in the rate setting. States
will need to work with their MCOs to
develop appropriate policies within
their contracts.
Comment: One commenter
recommended that CMS reinforce the
importance of State compliance with the
requirement that Medicaid managed
care rate setting must be actuarially
sound.
Response: The requirements of this
final rule do not in any way preempt
regulatory provisions otherwise in
effect. We urge States to work with all
of their provider communities to
determine the best ways in which to
implement related nonpayment policies.
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
10. Comment Period
Comment: A few commenters
objected to the 30-day comment period.
One commenter proposed that CMS
issue a final rule with comment period
to accept additional public comment
and to provide additional time for States
to articulate how they might comply
with the regulations.
Response: This rule does not present
a high level of complexity and we
believe that the 30-day comment period
provided commenters sufficient time to
fully evaluate the proposed rule and
submit comments to CMS. The 30-day
comment period is consistent with the
requirements of the Administrative
Procedure Act codified at 5 U.S.C. 553,
and a longer period is not warranted in
light of the significant beneficiary
protection that this rule would
implement. For the same reasons, we do
not agree that issuing a final rule with
comment period is necessary.
B. Access to Care
Section 2702(a) of the Affordable Care
Act requires that the Secretary ensure
that adjustments to payment rates under
this section do not result in a loss of
access to care for beneficiaries. To this
end, we proposed that any reduction in
payment would be limited to the
amounts directly identifiable as related
to the PPC and the resulting treatment.
We received the following comments
in response to our proposals concerning
access to care.
Comment: One commenter stated that
hospitals should not be penalized
multiple times for the same occurrence.
Response: We agree and urge provider
communities to engage States to ensure
that methodologies implemented do not
unduly impact providers.
Comment: Several commenters
requested that we include a provider
appeals process in these provisions. The
commenters noted that the nature of
identified conditions and the variation
in State payment policies warranted the
inclusion.
Response: Existing State appeal
processes may be available for a
provider to contest whether a State has
improperly identified the occurrence of
a condition identified as a PPC. We
encourage States to develop appeals
processes that will allow providers to
object to any payment reduction when
the provider can show that an identified
PPC occurred despite all appropriate
precaution.
Comment: Some commenters opined
that allowing States any flexibility in
defining PPC through the OPPC category
would be an undue burden on providers
who operate on a multistate basis.
PO 00000
Frm 00015
Fmt 4701
Sfmt 4700
32829
Response: The underlying authority
for this rule is found in provisions of
title XIX of the Act that predated section
2702 of the Affordable Care Act. The
proposed rule was supported by our
existing authority under sections 1102,
1902(a)(19), and 1902(a)(30) of the Act.
Providers that operate on a multistate
basis must comply with the laws and
rules of each State in which they
operate. We see no compelling reason to
limit State flexibility to identify PPC
nonpayment rules to ensure high quality
services for beneficiaries.
Comment: One commenter opposed
the idea of States being allowed to
define potential PPC and opined that
this task was better left to national
quality organizations such as NQF or
IOM. While expressing support for the
general concept of evidence-based
quality standards, the commenter
believed that it was important that these
standards be national in scope and that
the use of State Medicaid payment
systems was not the appropriate vehicle
for improvement of health care quality.
Response: The Medicaid program, by
its very nature, is a partnership between
the Federal and State governments, and
is administered by States. While we are
requiring that States rely on a review of
medical literature by qualified
professionals to identify evidence-based
PPCs, we believe it is essential to allow
States flexibility to develop payment
strategies that provide strong incentives
for high quality services.
Comment: Several commenters
recommended that we limit State ability
to create PPCs to only those which
strictly met the Medicare criteria in
section 1886 (d)(4)(D)(iv) of the Act.
Response: Section 2702 of the
Affordable Care Act requires that the
Secretary by rulemaking, establish a
nonpayment policy for HCACs, the
underlying authority for this rule is
found in provisions of title XIX of the
Act. The proposed rule was supported
by our existing authority under sections
1102, 1902(a)(19), and 1902(a)(30) of the
Act and States, using this authority,
have already undertaken payment
policies to drive quality outcomes. We
see no compelling reason to limit State
flexibility to identify PPC nonpayment
rules to ensure high quality services for
beneficiaries.
Comment: One commenter was
supportive of the proposed regulation
and of the addition of non-hospital
providers through the OPPC category.
The commenter suggested careful CMS
scrutiny of proposed State PPC SPAs to
assure no adverse impact on beneficiary
access to care, the addition of a riskadjustment mechanism to the
regulation, careful monitoring to assure
E:\FR\FM\06JNR2.SGM
06JNR2
mstockstill on DSK4VPTVN1PROD with RULES2
32830
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
that no access problems develop, and
some mechanism to publicly report
provider outcomes. The Maryland
Medicaid model for PPC payment and
reporting was offered as an exemplary
model for national use.
Response: We reviewed the Maryland
system in developing this regulation
and, found it to be a useful State model
that combined both financial incentives
with overall quality improvement
efforts. CMS will review State preprints,
reimbursement State plan amendments,
and supplementary information to
determine final action on State PPC
policies.
Comment: Some commenters
expressed concern that the proposed
regulation allowed too much discretion
to individual States to use the SPA
process to affect payment in areas where
no national consensus about appropriate
care existed.
Response: We are strongly committed
to permitting State flexibility to
innovate in this area. State innovation
has been a significant driver of Federal
policy, and States have direct
experience with utilization and claims
review for Medicaid services. While we
anticipate that States will review data to
identify evidence-based PPCs, we
believe it is essential to allow States
flexibility to develop payment strategies
that provide strong incentives for high
quality services.
The SPA review process will give
CMS and providers the opportunity to
consider State policy before it is
implemented and to provide guidance
and input based on our knowledge of
the issues.
Comment: Several commenters
expressed concern that the language of
the proposed regulation allowed States
excessive authority to use the PPC
process to further reduce Medicaid
compensation during a period when
States are already under financial
pressure to reduce Medicaid costs. One
commenter suggested numerous
additional limitations of State use of the
PPC process be added to the final
regulation.
Response: This final rule provides for
nonpayment to the extent that an
identified PPC would otherwise result
in an increase in payment for additional
services, and permits States to identify
PPCs in addition to the core PPCs that
are based on Medicare. This is
consistent with the considerable
flexibility that States have in setting
payment rates and methodologies.
States will need to file SPAs with CMS
outlining the State’s proposed
nonpayment methodology, and their
approach to inclusion of Federal
minimum standards, as well as any
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
additional variations proposed by the
State. The SPA process will allow the
State’s providers to file public
comments on any proposed State
changes.
Comment: Several commenters
expressed concern over how the
nonpayment policy would be
implemented in States that do not use
MS–DRG reimbursement systems. A few
commenters requested that States that
have elected to use per-diem, global
payment, bundled payment or other
non-MS–DRG systems to reimburse
hospitals be allowed to continue to do
so, and not be forced to move to MS–
DRG.
Commenters were concerned that
these States will need to identify
methods appropriate to their
reimbursement mechanisms to make
payment reductions for PPCs and that
resource-intensive post payment audits
and payment adjustments are likely to
be necessary. These commenters noted
that they are encouraged by our attempt
to provide flexibility to States, but
requested that we issue guidance that
includes best practice recommendations
for developing efficient payment
adjustments where reimbursement is
not based on an MS–DRG system.
Another commenter requested that we
provide options for how States may
identify or estimate the cost of services
on a systematic basis without a case by
case review. One commenter requested
that we develop a crosswalk of HCAC
conditions to non-DRG payment
methodologies to assure consistency in
reporting from States back to CMS. The
commenter remarks that encouraging
States and MCOs to create their own
crosswalks will be counter-productive.
Response: CMS recognizes that many
States do not use MS–DRG to reimburse
hospital providers. As stated in the
NPRM, we have no intention of
requiring States to alter their current
compensation systems to comply with
this final regulation beyond the
necessary adjustments needed to
implement the PPCs non-payment
provisions. This intention continues
through the final rule.
States have flexibility to design their
own payment systems within the
guidelines of Federal regulations. The
final rule allows States the flexibility to
implement nonpayment policies
through various mechanisms, but
requires that States submit Medicaid
SPAs setting forth their mechanism to
comply with the required nonpayment
for PPCs, with public notice for CMS
approval. States will need to work with
their provider communities, industry
partners, and CMS to determine the
most effective manner in which to
PO 00000
Frm 00016
Fmt 4701
Sfmt 4700
implement these nonpayment
provisions. As we noted in the preamble
to the proposed rule, we intend to
continue to gather and share
information related to States’
implementation of PPCs nonpayment
policies. However, we do not intend to
endorse any particular best practices.
We do not wish to limit State
flexibility by dictating methods in
which PPCs should be translated or
‘‘cross walked’’ to individual State
payment systems. However, we do agree
that there is a need for as much
consistency as possible in reporting
from States to CMS. As a requirement of
the final rule, States will implement the
provider self-reporting through payment
claims systems regardless of the
provider’s intention to bill. We are
working to ensure that States
consistently report at least the minimum
requirements of the rule through the
Medicaid Management Information
Systems (MMIS). We anticipate that
States and providers, especially those
groups of providers that have not been
subject to Medicare’s HAC policy, will
need additional time to develop and
implement reporting systems that would
complement existing payment
structures. As discussed in the proposed
rule, a reporting component is essential
to building an effective PPC policy for
a number of reasons, including State
and CMS ability to capture data related
to these occurrences.
Comment: A few commenters
believed that it is unjust to penalize
providers for complications that occur
despite best evidence-based efforts to
eliminate or avoid them. Commenters
noted that some conditions have more
to do with patient risk factors or patient
compliance than with quality of care.
Another commenter stated that not
covering these conditions would
encourage denial of care to high risk
patient or a mass exodus of providers.
Several commenters suggested that
appeals processes be included in State
Medicaid PPCs provisions that would
allow providers to challenge payment
denials.
Response: We agree that not all of the
identified events will be avoidable in
100 percent of the cases even with
appropriate precautions. But current
Medicaid payment systems are designed
to provide incentives to providers to
efficiently provide high quality care and
result in an aggregate payment that may
be more or less than actual costs in a
particular case. For example, payment is
often based on a fee schedule or
diagnosis related group methodology
that considers average or target costs of
the particular service or services and
may differ from actual costs in a
E:\FR\FM\06JNR2.SGM
06JNR2
mstockstill on DSK4VPTVN1PROD with RULES2
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
particular case. Even ‘‘reasonable cost’’
rates do not necessarily include all costs
a provider may incur. It is important to
remember that the identified conditions
have been determined through
evidence-based medicine to be provider
preventable. For the issue of appeal
rights, existing State appeal processes
may be available for a provider to
contest whether a State has improperly
identified the occurrence of a condition
identified as a PPC. We encourage States
to develop appeals processes that will
allow providers to object to any
payment reduction when the provider
can show that an identified PPC
occurred despite all appropriate
precaution.
Comment: One commenter suggested,
as an example, that we consider
permitting Medicaid coordinated care
plans to adopt inpatient concurrent
review as a practice for addressing
PPCs. The commenter noted that, ‘‘most
Medicaid coordinated care plans utilize
inpatient concurrent review as a unique
reimbursement practice for addressing
PPCs. Most Medicaid coordinated care
plans utilize inpatient concurrent
review to identify hospital days that are
not medically necessary or represent
delays in care. These days are generally
not eligible for reimbursement in a nonDRG/per-diem environment. Expanding
the concurrent review process to
include identification of hospital days
required solely for the treatment of PPCs
would be one way to address this issue.’’
Response: This is one example of how
States may be able to identify amounts
related to the treatment of PPCs. The
final rule indicates that States may
reduce payments to providers when the
PPC would otherwise result in an
increase in payment. The rule also
requires that the State be able to
reasonably isolate for nonpayment the
portion of payment directly related to
treatment for, and related to, the PPC.
The rule does not limit State flexibility
in accomplishing these requirements.
Comment: One commenter asked that
we clarify that it recognizes that
different reimbursement methodologies
may result in no reduction or different
reductions than the reductions under
MS–DRGs. Another commenter asked
that we confirm that, ‘‘if on the same
inpatient hospital day, both services
associated with a PPC and services not
associated with a PPC are rendered and
if payment is made on a per diem basis
such that the presence of the PPC
services would not result in an
increased per diem payment even
without this proposed regulation, then
no adjustment to the payment for that
day is necessary.’’
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
Response: We agree that given the
variations in Medicaid payment
methodologies and systems across
States, there may be differences in
amounts identified for nonpayment
based on the payment system employed
by the individual State. And there is no
requirement that State Medicaid
payment adjustments to providers
correlate specifically to Medicare’s
payment adjustments for those same
conditions. Payment methodologies are
extremely complex, and we do not
believe it is productive to address broad
hypothetical scenarios regarding
implementation of nonpayment
policies. We intend to work with each
State to develop implementation
strategies that make sense with its
particular payment methodologies.
Comment: Some commenters
recommended that risk-adjustment be
incorporated into PPCs policies.
Response: These comments appear to
refer to payment methodologies that
provide for case-mix adjustments to give
higher payments to providers that treat
sicker populations, to reflect the higher
cost of treating such populations. Such
methodologies are not related to the
policies relating to PPCs that are
reflected in this rule, and to combine
the two would significantly weaken the
incentives for providers to institute
preventive measures to eliminate PPCs.
We note that we strongly support the
incorporation of risk-adjustment in State
Medicaid programs, which States can
elect under current law. We are urging
provider communities to continue to
work with States to develop successful
risk-adjustment approaches on the State
level.
Comment: One commenter suggested
that hospitals which serve Medicare and
Medicaid beneficiaries will decrease in
quality as a result of the proposed
policy because the fixed costs associated
with providing medical services will
become variable, and instead of
absorbing the loss, investors will simply
reduce capital investments. The
commenter offers that one solution to
this possible undesired consequence is
to have the Medicaid and Medicare
programs absorb such costs, albeit not
through direct payments. Instead, the
commenter suggested CMS could pay a
flat rate at the beginning of the year
covering all PPCs and require them to be
fully serviced without charge. This way,
they will still have the incentive to
reduce HCACs but will not have to bear
the costs.
Response: The policy set forth in this
rule is designed to improve quality of
services by providing a strong incentive
for providers to take steps eliminate the
incidence of preventable conditions. A
PO 00000
Frm 00017
Fmt 4701
Sfmt 4700
32831
provider that does so will suffer no
economic loss. In contrast, the flat rate
payment approach proposed by the
commenter would lock in a tolerance
level for such conditions, instead of
eliminating them, and would send a
mixed message to providers about
whether providers must take steps to
eliminate preventable conditions.
C. Effective Date of the Final Provisions
Consistent with the provisions of
section 2702(a) of the Affordable Care
Act, we proposed to make these
requirements effective July 1, 2011. In
the proposed rule, we requested that
States submit conforming SPAs to
implement these provisions prior to that
date. To be in compliance with the July
1, 2011 effective date, under § 430.20,
we proposed that the last date a SPA
may be submitted is September 30,
2011, which is the last day of the
quarter in which the amendment would
be effective.
We received the following comments
in response to our proposals concerning
the effective date.
Comment: Several commenters
expressed concern that the July 1, 2011
effective date of the rule does not leave
sufficient time for discussion of policy,
implementation of required hospital
changes, and development of the
appropriate systems for reporting.
Additionally, commenters suggested
that States be permitted up to 60 days
to incorporate Medicare HACs as
Medicare updates its list.
Response: We are statutorily-required
to implement these regulations effective
July 1, 2011. We do believe, however,
that States may need additional time to
work with providers to implement
sound policies and reporting
mechanisms. We intend to delay
compliance action on these provisions
until July 1, 2012.
We disagree that this final rule should
provide States up to 60 days to
incorporate additional Medicare HACs
as Medicare’s list changes. The
publication of Medicare’s final IPPS rule
is consistent and published in ample
time to allow States to incorporate HAC
changes. The Medicaid SPA process
allows States sufficient time to propose
and incorporate any changes that
Medicare may make to its HAC list
considering the timeframe in which
Medicare publishes its final rule.
Comment: One commenter
recommended that CMS not penalize
States that are not prepared to
implement the proposed Medicaid
nonpayment policy or any future
updates in a timely manner due to a
vender not modifying necessary
software in a timely manner.
E:\FR\FM\06JNR2.SGM
06JNR2
32832
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES2
Response: States have great flexibility
in administering their programs. We
urge States to work with their provider
communities and vendors to ensure that
they meet the provisions of these rules
in a timely fashion.
D. Specific Revisions to Regulations
Text
The provisions of the proposed rule
would deny FFP for Medicaid
expenditures made for PPCs, including
HCACs and OPPCs identified in the
State plan; and would ensure that
related payment adjustments do not
limit beneficiary access to care. These
provisions, as proposed, would apply to
payments as specified under States’
approved Medicaid State plans,
effective no later than July 1, 2011. We
proposed to modify the regulations at 42
CFR parts 434, 438, and 447 following
general provider payment rules and
preceding other provisions concerning
reductions in provider payments. In
addition, to ensure that these provisions
apply to contracts that States use to
provide Medicaid benefits using a
managed care delivery system, we
proposed to modify the regulations at 42
CFR part 438.
Currently, the general rules regarding
Medicaid State plan payments for
Medicaid are provided at part 447
subpart A. We proposed to add a new
§ 447.26 to indicate that FFP will not be
available for expenditures made for
PPCs. We have included in § 447.26(a)
a statement of the basis and purpose for
the regulation, and in § 447.26(b), the
definitions for the umbrella term PPCs,
and the included terms HCACs, and
other PPCs. We proposed to establish
Medicare as the floor that all States
must adopt, but allow flexibility for
States to move beyond the Medicare
definitions and settings. As States’
programs evolve and they make
additional requirements, we will require
that necessary SPAs be submitted for
implementation purposes.
In § 447.26(c), we proposed to set
forth the general rule that State plans
must preclude payment to providers for
PPCs, and that FFP is not available for
State expenditures for PPCs. To ensure
beneficiary access to care, we specified
that any reductions may be limited to
the added cost resulting from the PPC.
In § 447.26(d), we have included a
provision that will require States to
require provider reporting of PPCs
associated with Medicaid claims, or
with courses of treatment for Medicaid
beneficiaries that would otherwise be
payable under Medicaid.
In addition to these changes in part
447, we proposed including a
requirement in § 434.6(a)(12) for
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
contracts for medical or administrative
services that contractors do not make
payment for PPCs, and require that
providers comply with the reporting
requirements in § 447.26(d) as a
condition of receiving payment.
Likewise, to ensure that these
provisions are included as required
elements in Medicaid managed care
contracts, we proposed including a
requirement in § 438.6(f)(2) that
contracts must comply with both
§ 434.6(a)(12) and § 447.26.
We proposed these particular
provisions because the information
gathered in preparation for issuing the
proposed rule indicated the need for a
consistent authority under which States
could implement PPC nonpayment
policies; a consistent approach to
identifying conditions for nonpayment;
a streamlined terminology to indicate
Medicaid HCAC payment policies; State
flexibility to implement provisions
suitable to their own systems; and a
consistent provider reporting platform.
We received the following comments
in response to our proposals to revise
the regulations text.
Comment: One commenter believed
that the language of the proposed
regulation could be construed to limit
payments even when the PPC condition
was present on admission or initiation
of provider treatment.
Response: The language in the
proposed regulation was intended to
cover only situations where payment
reduction was being applied to
treatment for a condition not present on
admission or commencement of
treatment by that provider. However, we
understand that clarifying the language
of the regulation to emphasize this point
would be helpful to and we have done
so in this final rule. New § 447.26(c)(3)
language explicitly states that ‘‘* * * no
reduction in payment for a PPC will be
imposed on a provider when the
condition defined as a PPC for a
particular patient existed prior to the
initiation of treatment for that patient by
that provider.’’ This was implied in the
previous language, but has now been
made explicit. We agree with the
comment and are providing this
clarification.
Comment: A number of commenters
requested that CMS clarify that the
HCAC category applies only to inpatient
hospitals.
Response: The final rule has revised
regulatory language to clarify that HCAC
category applies to all Medicaid
inpatient hospital settings.
Comment: One commenter expressed
concern that expansion of PPC to
nonhospital providers threatened the
access of Medicaid beneficiaries to care.
PO 00000
Frm 00018
Fmt 4701
Sfmt 4700
In particular, commenters asked CMS to
clarify that Medicaid payment
disallowance for PPC would not apply
when the PPC was present at the time
the provider commenced treatment of
the patient.
Response: The language in the
proposed regulation was intended to
cover only situations where payment
reduction was being applied to
treatment for a condition not present on
admission or commencement of
treatment by that provider. However, we
understand that clarifying the language
of the regulation to emphasize this point
would be helpful and we have done so
in this final rule. New § 447.26(c)(2)
language explicitly states that ‘‘* * * no
reduction in payment for a PPC will be
imposed on a provider when the
condition defined as a PPC for a
particular patient existed prior to the
initiation of treatment for that patient by
that provider.’’ This was implied in the
previous language, but has now been
made explicit. CMS agrees with the
comment and is providing this
clarification.
Comment: A few commenters
believed that the distinctions among the
terms in the proposed rule were
confusing and made it hard to
understand which term applied to
which criteria.
Response: We have revised the
regulatory text to make it clear that
provider preventable conditions are
clearly defined into two separate
categories, healthcare acquired
conditions (Medicare’s HACs applicable
only to inpatient hospital providers paid
under the IPPS) and other providerpreventable conditions (conditions
minimally defined as Medicare’s 3
NCDs, applicable in any healthcare
service setting).
Comment: One commenter requested
clarification on the purpose of provider
reporting and how CMS expects States
to use reported information. Another
commenter noted that there is no clear
provision on how States are to report
this data to CMS. One State questioned
whether the SPA will have to specify
how the reporting will be done, or if
States will need to assure that they will
comply with the requirement.
Response: We are requiring that States
impose provider self-reporting through
claims systems because that information
will be fed by States to CMS. CMS and
States will use this data to inform policy
making. Language assuring compliance
with this provision is incorporated in
the State plan pre-print associated with
this provision.
Comment: One commenter supports
nonpayment for all PPCs as they pertain
to the dual eligible population. This
E:\FR\FM\06JNR2.SGM
06JNR2
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
commenter urges CMS to codify
provisions that prohibit Medicaid claim
payment for claims that have been
denied by Medicare based on the
presence of a HAC.
Response: This is a significant area of
concern, and we have revised the final
regulation to clarify the prohibition on
Medicaid payment for claims that have
been denied (in full or in part) by
Medicare, to reflect this
recommendation.
Comment: One commenter noted that
the proposed rule requires States to
establish a provider reporting
requirement for PPCs and requested that
amend the final rule to allow States time
to implement the PPC policies in
general.
Response: As a requirement of the
final rule, States will implement the
provider self-reporting through payment
claims systems regardless of the
provider’s intention to bill. We
anticipate that States and providers,
especially those groups of providers that
have not been subject to Medicare’s
HAC policy, will need to work
collaboratively to develop and
implement reporting systems that would
complement existing payment
structures.
III. Provisions of the Final Rule
mstockstill on DSK4VPTVN1PROD with RULES2
This final rule incorporates the
provisions of the proposed rule with the
following exceptions.
In § 447.26(b), we are revising the
definition of health care-acquired
condition to mean a condition occurring
in any inpatient hospital setting,
identified as a HAC by the Secretary
under section 1886(d)(4)(D)(iv) of the
Act for purposes of the Medicare
program identified in the State plan as
described in section 1886(d)(4)(D)(ii)
and (iv) of the Act; other than Deep Vein
Thrombosis (DVT)/Pulmonary
Embolism (PE) related to total knee
replacement or hip replacement surgery
in pediatric and/or obstetric patients.
In § 447.26(c)(1), we are revising the
language to read ‘‘A State plan must
provide that no medical assistance will
be paid for ‘‘provider-preventable
conditions’’ as defined in this section;
and as applicable for individuals dually
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
eligible for both the Medicare and
Medicaid programs.’’
IV. Collection of Information
Requirements
Under the Paperwork Reduction Act
of 1995, we are required to provide 60day notice in the Federal Register and
solicit public comment before a
collection of information requirement is
submitted to the Office of Management
and Budget (OMB) for review and
approval. In order to fairly evaluate
whether an information collection
should be approved by OMB, section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires that we
solicit comment on the following issues:
• The need for the information
collection and its usefulness in carrying
out the proper functions of our agency.
• The accuracy of our estimate of the
information collection burden.
• The quality, utility, and clarity of
the information to be collected.
• Recommendations to minimize the
information collection burden on the
affected public, including automated
collection techniques.
In accordance with the Act, we
solicited public comments on the
proposed collection of information, with
a 30-day comment period, in the
proposed rule that published on
February 17, 2011 (76 FR 9283). We did
not receive any substantive comments
related to the proposed information
collection requirements or burdens and,
therefore, we are retaining the following
requirements and estimates that were
set out in the proposed rule.
A. ICRs Regarding Contract
Requirements (§ 438.6)
Section 438.6(f)(2) will also require
States which provide medical assistance
using a managed care delivery system to
modify their managed care contracts to
reflect the PPCs payment adjustment
policies as applied through these
regulations. The burden associated with
this requirement is the time and effort
necessary for a State to amend its
managed care contracts to reflect these
policies. We estimated that 48 States
will be required to comply with this
requirement. We also estimated that it
will take 8 hours for each State to revise
PO 00000
Frm 00019
Fmt 4701
Sfmt 4700
32833
its contracts to comply with this
requirement and submit the amended
contract to CMS for review and
approval. The total estimated annual
burden associated with this requirement
is 384 hours at a cost of $20.67 per hour
per State.
B. ICRs Regarding the Prohibition on
Payment for Provider-Preventable
Conditions (§ 447.26)
Effective July 1, 2011, § Section
447.26(c)(1) will require States to
submit SPAs for CMS approval that
would reduce payments to providers by
amounts related to PPCs. The burden
associated with this requirement will be
the time and effort necessary for a State
to submit its SPA and the associated
pre-print. We estimated that 50 States,
the District of Columbia, and Territories
will be required to comply with this
requirement. We further estimated that
it will take each State 7 hours to submit
the aforementioned documentation to
CMS. The total estimated burden
associated with this requirement would
be 385 hours at a cost of $20.67 per hour
per State.
We estimated that it will take each
State 7 hours because we intend to issue
a template to States to simplify the
process of making the related
amendment to the Medicaid State plan.
Section 447.26(c)(2) will also require
States to implement provider reporting
requirements to ensure that PPCs are
identified in claims for Medicaid
payment. The burden associated with
this requirement is the time and effort
necessary to develop and implement
provider reporting requirements that are
effective with the provisions of this
regulation. We estimated that 50 States,
the District of Columbia, and Territories
will be required to comply with this
requirement. We estimated that it will
take 24 hours for each State to develop
and implement the provider reporting
requirements as specified above. The
total estimated burden associated with
this requirement will be 1320 hours at
a cost of $20.67 per hour per State. We
believe that this estimate is reasonable
because we are requiring that States
have providers use their existing claims
processes to report identified events.
E:\FR\FM\06JNR2.SGM
06JNR2
32834
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
TABLE 1—ANNUAL RECORDKEEPING AND REPORTING REQUIREMENTS
Regulation section(s)
OMB
Control
No.
438.6(f)(2) .................................
447.26(c)(1) ..............................
447.26(c)(2) ..............................
Total ..................................
Burden
per
response
(hours)
Hourly
labor
cost of
reporting
($)
Total
annual
burden
(hours)
Total labor
cost of
reporting
($)
Total
capital/
maintenance
costs
($)
Number of
respondents
Number of
responses
0938–NEW .....
0938–NEW .....
0938–NEW .....
48
55
55
48
55
55
8
7
24
384
385
1,320
20.67
20.67
20.67
7,937.28
7957.95
27,284.4
0
0
0
7,937.28
7,957.5
27,284.4
........................
158
158
39
2089
..................
....................
0
43,179.18
The estimated annual burden
associated with the requirements under
438.6(f)(2), 447.26(c)(1), and
447.26(c)(2) is 2,089 hours (total) at a
Total cost
($)
cost of $43,179.18 (total) or $806.13 (per
State).
TABLE 2—ANNUAL RECORDKEEPING AND REPORTING REQUIREMENTS
Burden
per
response
(hours)
Hourly
labor
cost of
reporting
($)
Total
annual
burden
(hours)
Total labor
cost of
reporting
($)
Total
capital/
maintenance
costs
($)
Regulation section(s)
OMB
Control
No.
438.6(f)(2) .................................
447.26(c)(1) ..............................
447.26(c)(2) ..............................
0938–NEW .....
0938–NEW .....
0938–NEW .....
48
50
50
48
50
50
8
7
24
384
350
1,200
20.67
20.67
20.67
7,937.28
7,234.5
2,4804
0
0
0
7,937.28
7,234.5
2,4804
Total ..................................
........................
98
148
39
1,934
..................
....................
0
39,975.78
Number of
respondents
Number of
responses
The estimated annual burden
associated with the requirements under
438.6(f)(2), 447.26(c)(1), and
447.26(c)(2) is 1,934 hours (total) at a
cost of $39,975.78 (total) or $806.13 (per
State).
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received by the OMB desk officer at
the address below, no later than 5 p.m.
on July 7, 2011.
OMB, Office of Information and
Regulatory Affairs, Attention: CMS Desk
Officer, Fax Number: (202) 395–5806.
Fax Number: (202) 395–6974.
V. Regulatory Impact Statement
mstockstill on DSK4VPTVN1PROD with RULES2
A. Statement of Need
This final rule implements section
2702 of the Affordable Care Act which
directs the Secretary to issue Medicaid
regulations effective as of July 2011,
prohibiting Federal payments to States
(under section 1903 of the Act) for any
amounts expended for providing
medical assistance for HCACs. It will
also authorize States to identify other
PPCs for which Medicaid payment
would be prohibited. We view this
regulation as one step of a larger
approach to address the problem of
PPCs.
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
B. Overall Impact
We have examined the impacts of this
rule as required by Executive Order
12866 on Regulatory Planning and
Review (September 30, 1993), Executive
Order 13563 on Improving Regulation
and Regulatory Review (February 2,
2011), the Regulatory Flexibility Act
(RFA) (September 19, 1980, Pub. L. 96–
354), section 1102(b) of the Act, section
202 of the Unfunded Mandates Reform
Act of 1995 (Pub. L. 104–4), Executive
Order 13132 on Federalism (August 4,
1999), and the Congressional Review
Act (5 U.S.C. 804(2)).
Executive Order 12866 directs
agencies to assess all costs and benefits
of available regulatory alternatives and,
if regulation is necessary, to select
regulatory approaches that maximize
net benefits (including potential
economic, environmental, public health
and safety effects, distributive impacts,
and equity). A regulatory impact
analysis (RIA) must be prepared for
major rules with economically
significant effects ($100 million or more
in any 1 year). This rule does not reach
the economic threshold and thus is not
considered a major rule under the
Congressional Review Act.
It is difficult to estimate the amount
which will be withheld from providers
under this regulation, as not all of these
events will be billed. However, it is
instructive to note that the total dollar
PO 00000
Frm 00020
Fmt 4701
Sfmt 4700
Total cost
($)
amount of Medicare claims denied
under its HAC policy is approximately
$20 million per year (see 75 FR 23895,
May 4, 2010). The original regulation
creating the Medicare HACs was
published in the August 19, 2008
Federal Register (73 FR 48433). In
addition, estimates were conducted by
the Congressional Budget Office (CBO)
and the CMS Office of the Actuary
(OACT) on the impact of section 2702
of the Affordable Care Act. The CBO
estimate concluded there would be no
impact associated with section 2702 of
the Affordable Care Act (CBO and JCT,
2010 Estimate). The CMS OACT
estimate (Estimated Financial Effects of
the ‘‘Patient Protection and Affordable
Care Act,’’ as Amended, 2010) projected
an impact from section 2702 of the
Affordable Care Act on the Medicaid
program of cost savings of $2 million for
FY 2011 ($1 million for the Federal
share and $1 million for the State share),
with an aggregate cost savings of $35
million ($20 million for the Federal
share and $15 million for the State
share) for FYs 2011 through 2015. The
Federal and State share cost savings, as
result of denied payments, are
represented by the reduction in transfers
from Medicaid to hospitals. These
estimates could be higher if States elect
to expand beyond the minimum
requirements of this rule.
E:\FR\FM\06JNR2.SGM
06JNR2
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
32835
TABLE 3—MEDICAID IMPACTS FOR FYS 2011 THROUGH 2015
FY impact ($ millions)
Medicaid impacts
2011
2012
2013
2014
2015
Total
¥1
¥1
¥4
¥3
¥5
¥3
¥5
¥4
¥5
¥4
¥20
¥15
Total ..................................................
mstockstill on DSK4VPTVN1PROD with RULES2
Federal Share ..........................................
State Share ..............................................
¥2
¥7
¥8
¥9
¥9
¥35
There are administrative cost impacts
on States to modify their systems to
meet reporting requirements, but we
believe these are not significant. As
noted above, the reporting system in
this final rule relies on an existing
billing system currently in place. Both
States and providers already have
billing, claiming, and payment systems
in place to act upon the information
obtained. The costs reported in section
IV of this final rule, Collection of
Information Requirements, amount to an
additional $39,976 dollars aggregate
across all States.
Hospitals may incur additional costs
to reduce PPCs. Such costs include
hiring additional nurses to ensure
enforcement of the infection prevention
policies. In turn, preventing or reducing
HCACs will lead to a reduction in direct
health spending, which is a benefit
realized by Medicaid, hospitals and
other payers.
The Joint Commission requires
hospitals to have established programs
for Quality Improvement, Risk
Management, Safety, and Infection
Control. As a result, a majority of
hospitals already have in place
programs to avert Medicare HACs and
thus would not incur new costs to
implement parallel programs to avert
Medicaid HCACs. Furthermore, we
anticipate a public benefit to all
providers and payers since programs
that hospitals develop to avoid
Medicaid HCACs will likely benefit all
patients and reduce health care costs.
Patient benefits resulting from a
reduction in HCAC may include an
increase in healthy years of life.
However, this public benefit will derive
from possible responses by hospitals
and not from this regulation itself.
We realize that the overall problem of
HCACs cannot be completely addressed
in this regulation, as this final
regulation is one step of an overall
approach. Consequently, the estimated
economic impacts from all HHS
initiatives to address HCACs may result
in much higher savings impact than
presented in this analysis. However,
such economic savings, for example,
will not derive from this regulation
alone, but will in part come from the
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
knowledge that State and Federal
governments gain from the reporting
requirements created by this regulation.
That knowledge will in turn inform
future HHS initiatives to reduce excess
morbidity and mortality attributable to
PPCs.
The RFA requires agencies to analyze
options for regulatory relief for small
entities, if a rule has a significant impact
on a substantial number of small
entities. Most hospitals, other providers,
and suppliers are small entities, either
by nonprofit status or by having
revenues of $7.0 million to $34.5
million in any 1 year. Individuals and
States are not included in the definition
of a small entity. Guidance issued by the
Department of Health and Human
Services interpreting the RFA considers
effects to be economically significant if
they reach a threshold of 3 to 5 percent
or more of total revenue or total costs.
As illustrated in Table 1, any decrease
in payments, as a result of this
regulation, to small entities should be
significantly less than this threshold.
Therefore, we are not preparing an
analysis for the RFA because the
Secretary has determined that this final
rule will not have a significant
economic impact on a substantial
number of small entities.
In addition, section 1102(b) of the Act
requires us to prepare a RIA if a rule
may have a significant impact on the
operations of a substantial number of
small rural hospitals. This analysis must
conform to the provisions of section 604
of the RFA. For purposes of section
1102(b) of the Act, we define a small
rural hospital as a hospital that is
located outside of a Metropolitan
Statistical Area for Medicare payment
regulations and has fewer than 100
beds. We are not preparing an analysis
for section 1102(b) of the Act because
the Secretary has determined that this
final rule will not have a significant
impact on the operations of a substantial
number of small rural hospitals.
Section 202 of the Unfunded
Mandates Reform Act of 1995 (UMRA)
also requires that agencies assess
anticipated costs and benefits before
issuing any rule whose mandates
require spending in any 1 year of $100
PO 00000
Frm 00021
Fmt 4701
Sfmt 4700
million in 1995 dollars, updated
annually for inflation. In 2011, that
threshold is approximately $136
million. This rule will have no
consequential effect on State, local, or
tribal governments in the aggregate or
on the private sector.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it promulgates a
proposed rule (and subsequent final
rule) that imposes substantial direct
requirement costs on State and local
governments, preempts State law, or
otherwise has Federalism implications.
While this regulation does not impose
substantial costs on State or local
governments, it does preempt some
State laws. The requirements of
Executive Order 13132 are applicable.
Executive Order 13132 sets forth a
process to be followed by the Federal
government whenever Federal
regulatory processes may affect or
preempt State regulations or laws. We
are aware that many States do have
regulations for Medicaid nonpayment in
the event that specified adverse events
occur during provider care. This final
rule is intended to create a Federal legal
minimum for such State regulations.
States could continue to enact more
stringent laws or regulations upon
approval of a Medicaid SPA by CMS to
assure that there is no adverse impact
on Medicaid beneficiary access to care.
This final rule derives from section
2702 of the Affordable Care Act and
other CMS statutory authority. Under
the requirements of Executive Order
13132 and the requirements of section
2702 of the Affordable Care Act, we
have consulted with the States before
issuing this final rule. Major portions of
the regulation are, in fact, derived from
comparable State regulations.
Significant regulatory authority in this
area would remain with the States
should the proposed regulation become
final. As stated, the final rule does not
completely preempt State law, but
merely sets a Federal minimum
standard.
We are meeting the requirements of
Executive Order 13132 by issuing this
final rule 30 days prior to the effective
E:\FR\FM\06JNR2.SGM
06JNR2
32836
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
date of July 1, 2011, set forth in the
Affordable Care Act.
payment provision, is primarily targeted
at preventing medical errors.
C. Anticipated Effects
2. Effects on Other Providers
We anticipate that these provisions
will prompt health care providers to
adopt quality programs that would limit
the risk of providing services or using
resources, in error, that will not be
reimbursed.
We anticipate that the reporting
requirements will ultimately be a
catalyst for providers in developing
quality practices to reduce the risks
associated with receiving care at their
facilities and promote overall quality
improvements.
mstockstill on DSK4VPTVN1PROD with RULES2
1. Effects on State Medicaid Programs
The effects on State Medicaid
programs as a result of this provision
will depend on various factors. For
instance, as we state in the preamble,
there are 21 States that have already
implemented similar policies. While we
have reviewed existing State policies
and incorporated those policies that we
believe would best apply on a national
level, these States will have to make
changes to comply with the minimums
set in this final rule. In addition, States
will have to work through the SPA
review process to ensure that their
existing policies do not serve to limit
beneficiaries’ access to healthcare.
The States that have used State plan
authority to implement their
nonpayment policies will need to
review their policies and ensure that
they comply with any final provisions
of these rules. These States will likely
have to submit revisions to their State
plans. In addition, the States that
implemented these policies through
some other authority like State law or
administrative procedures will have to
submit new SPAs for review and work
with CMS to ensure that their policies
effective July 1, 2011, are in line with
the final provisions of these rules. States
that have elected not to implement
Medicaid specific policies or that do not
have related policies at all will need to
submit new SPAs. Further, States which
use a managed care delivery system to
provide Medicaid benefits to
beneficiaries will have to amend and
submit for CMS review and approval
managed care contracts that reflect these
new requirements. While this regulation
is effective on July 1, 2011, most States
will already have their managed care
contracts for the fiscal year in place by
that time and there may be some delay
in incorporating new language in their
managed care contracts. We will issue
subregulatory guidance to States
requiring that appropriate changes be
made to managed care contracts to
comply with the regulation.
All States will need to incorporate the
reporting requirements into their claims
systems. In addition, States will need to
evaluate the best ways in which to
identify and reduce payment for PPCs
under their respective Medicaid plans.
We anticipate that this provision will
prompt programmatic changes for States
regarding quality improvement
considerations within health care
systems. This provision, while it is a
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
3. Effects on the Medicaid Program
Medicare’s and States’ experience has
demonstrated that related policies often
do not produce substantial short-term
financial savings within health care
systems. Medicare estimated that the
policy will reduce its spending by an
aggregate amount of about $80,000,000
from FY 2009 through FY 2013, or by
less than 0.01 percent of total annual
spending on inpatient hospital services
(75 FR 50661). States report similar
short-term savings. However, there are
more significant gains to be realized
when considering the broader impact of
increased quality on the health system
overall, or more exactly the savings
created when preventable conditions
and related treatment are measured.
The anticipated public benefit to all
providers and payers from programs
that hospitals develop to avoid
Medicaid HCACs will likely benefit all
patients and reduce health care costs.
This includes, for example, Medicaid
beneficiaries realizing an increase in
healthy years of life as a result of the
reduction in HCACs. However, this
public benefit will derive from possible
responses by hospitals and not from this
regulation itself.
D. Alternatives Considered: Conditions
Identified as Provider-Preventable
Conditions
The statute requires that Medicaid, at
a minimum, recognize Medicare’s
current list of HACs. We considered
proposing regulatory action that
included only the conditions listed as
Medicare HACs. However, when
considering current State practices our
research concluded that many States’
policies included conditions not
identified by Medicare as HACs. We
concluded that such limited action
would not serve the program purposes
of ensuring high quality care and would
potentially limit State flexibility to
protect beneficiaries and program
integrity. Similarly, we considered
PO 00000
Frm 00022
Fmt 4701
Sfmt 4700
proposing regulatory action that
included only the inpatient hospital
setting. Again, after assessing current
State practices, as well as industrybased research, there is clear indication
that data is available to States that will
allow them to employ evidence based
policy practices beyond the inpatient
hospital setting. To provide States full
flexibility to protect beneficiaries and
the program, we elected the more
comprehensive approach that we
discussed in the proposed rule. We
considered defining OPPC as, ‘‘a
condition occurring in any health care
setting that could have reasonably been
prevented through the ordinary
provision of high quality care during the
course of treatment * * *’’ We believed
that this terminology would limit
additional requirements on States to
produce evidence of preventability.
However, after discussing the
terminology and scientific parameters
that exist in relation to this issue, we
proposed that the term be defined as, ‘‘a
condition that could have reasonably
been prevented through the application
of evidence based guidelines.’’
E. Conclusion
For the reasons outlined in the RIA,
we are not preparing an analysis for
either the RFA or section 1102(b) of the
Act because we have determined that
this final rule would not have a direct
significant economic impact on a
substantial number of small entities or
a direct significant impact on the
operations of a substantial number of
small rural hospitals.
In accordance with the provisions of
Executive Order 12866, this regulation
was reviewed by the Office of
Management and Budget.
List of Subjects
42 CFR Part 434
Grant programs—health, Health
maintenance organizations (HMO),
Medicaid, Reporting and recordkeeping
requirements.
42 CFR Part 438
Grant programs—health, Medicaid,
Reporting and recordkeeping
requirements.
42 CFR Part 447
Accounting, Administrative practice
and procedure, Drugs, Grant programs—
health, Health facilities, Health
professions, Medicaid, Reporting and
recordkeeping requirements, Rural
areas.
For the reasons set forth in the
preamble, the Centers for Medicare &
Medicaid Services amends 42 CFR parts
434, 438, and 447, as set forth below:
E:\FR\FM\06JNR2.SGM
06JNR2
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
PART 434—CONTRACTS
1. The authority citation for part 434
continues to read as follows:
■
Authority: Sec. 1102 of the Social Security
Act (42 U.S.C. 1302).
Subpart A—General Provisions
2. Section 434.6 is amended by—
A. Revising the introductory text of
paragraph (a).
■ B. Removing the semicolons from the
end of paragraphs (a)(1) through (a)(9),
and the semicolon and the word ‘‘and’’
from the end of paragraph (a)(10) and
replacing them with a period.
■ C. Adding a new paragraph (a)(12).
The revision and addition read as
follows:
■
■
§ 434.6 General requirements for all
contracts and subcontracts.
(a) Contracts. All contracts under this
part must include all of the following:
* * *
(12) Specify the following:
(i) No payment will be made by the
contractor to a provider for providerpreventable conditions, as identified in
the State plan.
(ii) The contractor will require that all
providers agree to comply with the
reporting requirements in § 447.26(d) of
this subchapter as a condition of
payment from the contractor.
(iii) The contractor will comply with
such reporting requirements to the
extent the contractor directly furnishes
services.
*
*
*
*
*
PART 438—MANAGED CARE
3. The authority citation for part 438
continues to read as follows:
■
Authority: Sec. 1102 of the Social Security
Act (42 U.S.C. 1302).
Subpart A—General Provisions
4. Section 438.6 is amended by
revising paragraph (f) to read as follows:
■
§ 438.6
Contract requirements.
mstockstill on DSK4VPTVN1PROD with RULES2
*
*
*
*
*
(f) Compliance with contracting rules.
All contracts must meet the following
provisions:
(1) Comply with all applicable
Federal and State laws and regulations
including title VI of the Civil Rights Act
of 1964; title IX of the Education
Amendments of 1972 (regarding
education programs and activities); the
Age Discrimination Act of 1975; the
Rehabilitation Act of 1973; and the
Americans with Disabilities Act of 1990
as amended.
(2) Provide for the following:
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
(i) Compliance with the requirements
mandating provider identification of
provider-preventable conditions as a
condition of payment, as well as the
prohibition against payment for
provider-preventable conditions as set
forth in § 434.6(a)(12) and § 447.26 of
this subchapter.
(ii) Reporting all identified providerpreventable conditions in a form or
frequency as may be specified by the
State.
(3) Meet all the requirements of this
section.
*
*
*
*
*
PART 447—PAYMENTS FOR
SERVICES
5. The authority citation for part 447
continues to read as follows:
■
Authority: Sec. 1102 of the Social Security
Act (42 U.S.C. 1302).
Subpart A—Payments: General
Provisions
6. Section 447.26 is added to read as
follows:
■
§ 447.26 Prohibition on payment for
provider-preventable conditions.
(a) Basis and purpose. The purpose of
this section is to protect Medicaid
beneficiaries and the Medicaid program
by prohibiting payments by States for
services related to provider-preventable
conditions.
(1) Section 2702 of the Affordable
Care Act requires that the Secretary
exercise authority to prohibit Federal
payment for certain provider
preventable conditions (PPCs) and
health care-acquired conditions
(HCACs).
(2) Section 1902(a)(19) of the Act
requires that States provide care and
services consistent with the best
interests of the recipients.
(3) Section 1902(a)(30) of the Act
requires that State payment methods
must be consistent with efficiency,
economy, and quality of care.
(b) Definitions. As used in this
section—
Health care-acquired condition means
a condition occurring in any inpatient
hospital setting, identified as a HAC by
the Secretary under section
1886(d)(4)(D)(iv) of the Act for purposes
of the Medicare program identified in
the State plan as described in section
1886(d)(4)(D)(ii) and (iv) of the Act;
other than Deep Vein Thrombosis
(DVT)/Pulmonary Embolism (PE) as
related to total knee replacement or hip
replacement surgery in pediatric and
obstetric patients.
Other provider-preventable condition
means a condition occurring in any
PO 00000
Frm 00023
Fmt 4701
Sfmt 4700
32837
health care setting that meets the
following criteria:
(i) Is identified in the State plan.
(ii) Has been found by the State, based
upon a review of medical literature by
qualified professionals, to be reasonably
preventable through the application of
procedures supported by evidencebased guidelines.
(iii) Has a negative consequence for
the beneficiary.
(iv) Is auditable.
(v) Includes, at a minimum, wrong
surgical or other invasive procedure
performed on a patient; surgical or other
invasive procedure performed on the
wrong body part; surgical or other
invasive procedure performed on the
wrong patient.
Provider-preventable condition means
a condition that meets the definition of
a ‘‘health care-acquired condition’’ or an
‘‘other provider-preventable condition’’
as defined in this section.
(c) General rules.
(1) A State plan must provide that no
medical assistance will be paid for
‘‘provider-preventable conditions’’ as
defined in this section; and as
applicable for individuals dually
eligible for both the Medicare and
Medicaid programs.
(2) No reduction in payment for a
provider preventable condition will be
imposed on a provider when the
condition defined as a PPC for a
particular patient existed prior to the
initiation of treatment for that patient by
that provider.
(3) Reductions in provider payment
may be limited to the extent that the
following apply:
(i) The identified providerpreventable conditions would otherwise
result in an increase in payment.
(ii) The State can reasonably isolate
for nonpayment the portion of the
payment directly related to treatment
for, and related to, the providerpreventable conditions.
(4) FFP will not be available for any
State expenditure for providerpreventable conditions.
(5) A State plan must ensure that nonpayment for provider-preventable
conditions does not prevent access to
services for Medicaid beneficiaries.
(d) Reporting. State plans must
require that providers identify providerpreventable conditions that are
associated with claims for Medicaid
payment or with courses of treatment
furnished to Medicaid patients for
which Medicaid payment would
otherwise be available.
Authority: (Catalog of Federal Domestic
Assistance Program No. 93.778, Medical
Assistance Program)
E:\FR\FM\06JNR2.SGM
06JNR2
32838
Federal Register / Vol. 76, No. 108 / Monday, June 6, 2011 / Rules and Regulations
Dated: May 25, 2011.
Donald M. Berwick,
Administrator, Centers for Medicare &
Medicaid Services.
Approved: May 27, 2011.
Kathleen Sebelius,
Secretary, Department of Health and Human
Services.
[FR Doc. 2011–13819 Filed 6–1–11; 11:15 am]
mstockstill on DSK4VPTVN1PROD with RULES2
BILLING CODE 4120–01–P
VerDate Mar<15>2010
17:36 Jun 03, 2011
Jkt 223001
PO 00000
Frm 00024
Fmt 4701
Sfmt 9990
E:\FR\FM\06JNR2.SGM
06JNR2
Agencies
[Federal Register Volume 76, Number 108 (Monday, June 6, 2011)]
[Rules and Regulations]
[Pages 32816-32838]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-13819]
[[Page 32815]]
Vol. 76
Monday,
No. 108
June 6, 2011
Part III
Department of Health and Human Services
-----------------------------------------------------------------------
Centers for Medicare & Medicaid Services
-----------------------------------------------------------------------
42 CFR Parts 434, 438, and 447
Medicaid Program; Payment Adjustment for Provider-Preventable
Conditions Including Health Care-Acquired Conditions; Final Rule
Federal Register / Vol. 76 , No. 108 / Monday, June 6, 2011 / Rules
and Regulations
[[Page 32816]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Parts 434, 438, and 447
[CMS-2400-F]
RIN 0938-AQ34
Medicaid Program; Payment Adjustment for Provider-Preventable
Conditions Including Health Care-Acquired Conditions
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This final rule will implement section 2702 of the Patient
Protection and Affordable Care Act which directs the Secretary of
Health and Human Services to issue Medicaid regulations effective as of
July 1, 2011 prohibiting Federal payments to States under section 1903
of the Social Security Act for any amounts expended for providing
medical assistance for health care-acquired conditions specified in the
regulation. It will also authorize States to identify other provider-
preventable conditions for which Medicaid payment will be prohibited.
DATES: These regulations are effective on July 1, 2011.
FOR FURTHER INFORMATION CONTACT: Venesa Day, (410) 786-8281, or Marsha
Lillie-Blanton, (410) 786-8856.
SUPPLEMENTARY INFORMATION:
Acronyms
To assist the reader, the following list of the acronyms are
used in this final rule:
AHRQ Agency for Healthcare Research and Quality
BPM Benefit Policy Manual
CABG Coronary artery bypass graft
CBO Congressional Budget Office
CDC Centers for Disease Control and Prevention
DVT Deep vein thrombosis
ESRD End-stage renal disease
DRA Deficit Reduction Act of 2005 (Pub. L. 109-171, enacted on
February 8, 2006)
FFP Federal financial participation
FY Fiscal year
HAC Hospital-acquired condition
HCAC Health care-acquired condition
ICR Information collection requirement
IH Inpatient Hospital
IPPS Inpatient prospective payment system
MS-DRG Diagnosis-related group
NCA National coverage analysis
NDC National coverage determination
NQF National Quality Forum
OACT [CMS] Office of the Actuary
OIG Office of Inspector General
OMB Office of Management and Budget
OPPC Other provider-preventable condition
PE Pulmonary embolism
POA Present on admission
PPC Provider-preventable condition
PRA Paperwork Reduction Act
RFA Regulatory Flexibility Act (September 19, 1980, Pub. L. 96-354)
RIA Regulatory impact analysis
SMDL State Medicaid Director Letter
SPA State plan amendment
UMRA Unfunded Mandates Reform Act of 1995 (Pub. L. 104-04, enacted
on March 22, 1995)
UTI Urinary tract infection
I. Background
Title XIX of the Social Security Act (the Act) authorizes Federal
grants to the States for Medicaid programs to provide medical
assistance to persons with limited income and resources. While Medicaid
programs are administered by the States, they are jointly financed by
the Federal and State governments. Each State establishes its own
eligibility standards, benefits packages, payment rates, and program
administration for Medicaid in accordance with Federal statutory and
regulatory requirements. Operating within broad Federal parameters,
States select eligibility groups, types, and range of services, payment
levels for services, and administrative and operating procedures. Each
State Medicaid program must be described and administered in accordance
with a Federally-approved ``State plan.'' This comprehensive document
describes the nature and scope of the State's Medicaid program, and
provides assurances that it will be administered in conformity with all
Federal requirements.
The Federal government pays its share of medical assistance
expenditures to the State on a quarterly basis according to a formula
described in sections 1903 and 1905(b) of the Act. Specifically,
section 1903 of the Act requires that the Secretary (except as
otherwise provided) pay to each State which has a plan approved under
title XIX, for each quarter, an amount equal to the Federal medical
assistance percentage of the total amount expended during such quarter
as medical assistance under the State plan.
Among the statutory requirements for Medicaid State plans, section
1902(a)(4) of the Act requires that State plans provide for methods of
administration as are found to be necessary by the Secretary for the
proper and efficient operation of the plan. Section 1902(a)(6) of the
Act requires that a State plan for medical assistance provide that the
State agency will make such reports, in such form and containing such
information, as the Secretary may from time-to-time require, and comply
with such provisions as the Secretary may from time-to-time find
necessary to assure the correctness and verification of such reports.
In addition, section 1902(a)(19) of the Act requires that a State plan
for medical assistance provide such safeguards as may be necessary to
assure that eligibility for care and services under the plan will be
determined, and such care and services will be provided, in a manner
consistent with simplicity of administration and the best interests of
the recipients.
A. The Medicare Program and Quality Improvements Made in the Deficit
Reduction Act of 2005 (DRA) (Pub. L. 109-171)
Title XVIII of the Act provides authority for the Secretary to
operate the Medicare program, which provides payment for certain
medical expenses for persons 65 years of age or older, certain disabled
individuals, and persons with end-stage renal disease (ESRD). Medicare
benefits include inpatient care, a wide range of medical services, and
outpatient prescription drugs.
The Medicare statute authorizes the Secretary, in the course of
operating the Medicare program, to develop, implement, and monitor
quality measures, as well as take other actions, to ensure the quality
of the care and services received by Medicare beneficiaries.
Payment under the Medicare program for inpatient hospital services
is generally based on the ``inpatient prospective payment system''
(IPPS) described in section 1886(d) of the Act. Hospitals receive a
payment for each inpatient discharge based in part on diagnosis codes
that identify a ``diagnosis-related group'' (MS-DRG). Assignment of an
MS-DRG can take into account the presence of secondary diagnoses, and
payment levels are also adjusted to account for a number of hospital-
specific factors.
Section 5001(a) of the Deficit Reduction Act of 2005 (Pub. L. 109-
171, enacted on February 8, 2006) (DRA) amended section 1886(b)(3)(B)
of the Act to expand the set of hospital quality measures collected by
Medicare. In particular, this provision directed the Secretary to start
collecting baseline measures set forth by the Institute of Medicine in
its November 2005 report. In FY 2008 and subsequent years, the
Secretary was required to add other measures that reflect consensus
among affected parties. The provision also allowed the Secretary to
replace and update existing quality measures. The statute mandates that
the Secretary establish a process for hospitals to review data that
will be made public
[[Page 32817]]
and, after that process is complete, requires the Secretary to post
measures on the Hospital Compare Internet Web site.
Section 5001(c) of the DRA amended section 1886(d)(4) of the Act to
adjust payment to hospitals for certain preventable hospital-acquired
conditions (HACs) identified by the Secretary. Specifically, under
section 1886(d)(4)(D)(iv) of the Act, the Secretary is required to
select codes associated with at least two conditions to be identified
as HACs. These conditions are required to have the following
characteristics: (a) High cost or high volume or both; (b) result in
the assignment of a case to a MS-DRG that has a higher payment when
present as a secondary diagnosis; and (c) could reasonably have been
prevented through the application of evidence-based guidelines. Section
5001(c) of the DRA provides for revision of the list of conditions from
time to time, as long as it contains at least two conditions.
B. Previously Specified Medicare HACs
Under the provisions of section 1886(d)(4)(D)(ii) of the Act, when
a HAC is not present on admission (POA), but is reported as a secondary
diagnosis associated with the hospitalization, the Medicare payment
under IPPS to the hospital may be reduced to reflect that the condition
was hospital-acquired. More specifically, the hospital discharge cannot
be assigned to a higher paying MS-DRG if the secondary diagnosis
associated with the HAC was the only reason for this assignment.
Since October 1, 2007, hospitals subject to the IPPS have been
required to submit information on Medicare claims specifying whether
diagnoses were POA. The POA indicator reporting requirement and the HAC
payment provision apply to IPPS hospitals only. This requirement does
not apply to hospitals exempt from the IPPS.
The following is a list of the Medicare HACs for FY 2011 (75 FR
50084 through 50085):
Foreign Object Retained After Surgery.
Air Embolism.
Blood Incompatibility.
Stage III and IV Pressure Ulcers.
Falls and Trauma.
+ Fractures.
+ Dislocations.
+ Intracranial Injuries.
+ Crushing Injuries.
+ Burns.
+ Electric Shock.
Manifestations of Poor Glycemic Control.
+ Diabetic Ketoacidosis.
+ Nonketotic Hyperosmolar Coma.
+ Hypoglycemic Coma.
+ Secondary Diabetes with Ketoacidosis.
+ Secondary Diabetes with Hyperosmolarity.
Catheter-Associated Urinary Tract Infection (UTI).
Vascular Catheter-Associated Infection.
Surgical Site Infection Following:
+ Coronary Artery Bypass Graft (CABG)--Mediastinitis.
+ Bariatric Surgery.
--Laparoscopic Gastric Bypass.
--Gastroenterostomy.
--Laparoscopic Gastric Restrictive Surgery.
+ Orthopedic Procedures.
--Spine.
--Neck.
--Shoulder.
--Elbow.
Deep Vein Thrombosis (DVT)/Pulmonary Embolism (PE).
+ Total Knee Replacement.
+ Hip Replacement.
The Secretary may revise this list upon review and does so through
notice and comment rulemaking.
C. Previously Specified Medicare National Coverage Determinations (NCD)
In 2002, the National Quality Forum (NQF) published ``Serious
Reportable Events in Healthcare: A Consensus Report'', which listed 27
adverse events that were ``serious, largely preventable and of concern
to both the public and health care providers.'' These events and
subsequent revisions to the list became known as ``never events.'' This
concept and need for the proposed reporting led to NQF's ``Consensus
Standards Maintenance Committee on Serious Reportable Events,'' which
maintains and updates the list which currently contains 29 items.
The Medicare program has addressed certain ``never events'' through
national coverage determinations (NCDs). Similar to any other patient
population, Medicare beneficiaries may experience serious injury and/or
death if they undergo erroneous surgical or other invasive procedures
and may require additional healthcare to correct adverse outcomes that
may result from such errors. To address and reduce the occurrence of
these surgeries, CMS issued three NCDs. Under these NCDs, CMS does not
cover a particular surgical or other invasive procedure to treat a
particular medical condition when the practitioner erroneously
performs: (1) A different procedure altogether; (2) the correct
procedure but on the wrong body part; or (3) the correct procedure but
on the wrong patient. Medicare will also not cover hospitalizations and
other services related to these non-covered procedures.
D. Prior Guidance on Medicaid HACs and NCDs in Response to Medicare's
Policy
Section 5001(c) of the DRA addressed only payment under the
Medicare IPPS and did not require that Medicaid implement nonpayment
policies for HACs. However, in light of the Medicare requirements, we
encouraged States to adopt payment prohibitions on provider claims for
HACs to coordinate with the Medicare prohibitions under section
1886(d)(4)(D) of the Act. To accomplish this task, we issued State
Medicaid Director Letter (SMDL) 08-004 on July 31, 2008. In
the July 31, 2008 SMDL, we noted that there was variation in how State
Medicaid programs had addressed such claims in the past. The letter
noted that nearly 20 States already had, or were considering,
eliminating payment for some or all of the 28 conditions on the NQF's
list of Serious Reported Events. Other States had more limited efforts
to deny payment for services related to such conditions because the
services were ``medically unnecessary'' in light of the primary
diagnosis.
Recognizing this variation and addressing the immediate concern of
the States over Federal cost-shifting that could result from the
Medicare HAC policy as applied to those who are dually-eligible for
Medicare and Medicaid, we took a flexible position in the July 31, 2008
SMDL guidance on State Medicaid handling of the issue. The SMDL
indicated that States seeking to implement HAC nonpayment policies
could do so by amending their Medicaid State plans to specify the
extent to which they would deny payment for an HAC. Those interested
only in avoiding secondary liability for Federal Medicare denials of
HACs and NCDs in the case of dual-eligibles could do so by amending
their State Plan to indicate that payment would not be available for
HACs and the procedures described in the three NCDs that are not paid
by Medicare. States that wanted broader payment prohibitions could
indicate that payment would not be available for conditions specified
in the State plan amendment (SPA), or that meet criteria identified in
the SPA.
E. Section 2702 of the Affordable Care Act
Section 2702 of the Affordable Care Act requires that the Secretary
implement Medicaid payment adjustments for health care-acquired
conditions (HCACs). Section 2702 of the
[[Page 32818]]
Affordable Care Act did not grant the Secretary new authorities,
indicating that existing statutory authorities are sufficient to
fulfill the obligation. Section 2702(a) of the Affordable Care Act sets
out a general framework for application of Medicare prohibitions on
payment for HCACs to the Medicaid program. Section 2702(a) of the
Affordable Care Act first directs the Secretary to identify current
State practices that prohibit payment for HCACs and to incorporate the
practices identified, or elements of such practices, which the
Secretary determines appropriate for application to the Medicaid
program in regulations. Section 2702(a) of the Affordable Care Act then
requires that, effective as of July 1, 2011, the Secretary prohibit
payments to States under section 1903 of the Act for any amounts
expended for providing medical assistance for HCACs specified in
regulations. Such regulations must ensure that the prohibition on
payment for HCACs shall not result in a loss of access to care or
services for Medicaid beneficiaries.
Section 2702(b) of the Affordable Care Act defines the term
``health care-acquired condition'' as ``a medical condition for which
an individual was diagnosed that could be identified by a secondary
diagnostic code described in section 1886(d)(4)(D)(iv) of the Act.''
Section 2702(c) of the Affordable Care Act specifically requires
that the Secretary, in carrying out section 2702 of the Affordable Care
Act, apply the regulations issued under section 1886(d)(4)(D) of the
Act relating to the prohibition of payments based on the presence of a
secondary diagnosis code specified by the Secretary in such
regulations, as appropriate for the Medicaid program. The Secretary may
exclude certain conditions identified under title XVIII of the Act for
nonpayment under title XIX of the Act when the Secretary finds the
inclusion of such conditions to be inapplicable to beneficiaries under
title XIX of the Act.
We believe, and confirmed through public comment, that
incorporating Medicare's HACs in Medicaid's policy is inherently
complex because of population differences across programs. We fully
understand that the HACs developed for Medicare's population will not
directly apply to various subsets of Medicaid's population. While we
have established Medicare as a baseline, we understand that States
will, through their payment policies, appropriately address these
differences.
F. Requirement To Review Existing State Practices Prohibiting
Nonpayment Policies for HCACs
Section 2702 of the Affordable Care Act requires that the Secretary
identify current State practices that prohibit payment for HCACs and
incorporate those practices, as appropriate, into Medicaid regulations.
To fulfill the statutory direction, we reviewed existing SPAs
originally submitted in response to the July 31, 2008 SMDL
(08-004). We also researched State HCAC-related nonpayment
policies that had been implemented outside of Medicaid State plans. We
reviewed State quality assurance programs, pay-for-performance
programs, reporting requirements and procedures, and payment systems.
We reviewed various articles, reports, summaries, and data bases
pertaining to States' existing practices concerning hospital and HCACs
and infections. For a list of the items considered, see the February
17, 2011 proposed rule (76 FR 9283, 9286 through 9287).
We discussed internally within CMS, as well as with interagency
partners at the Agency for Healthcare Research and Quality (AHRQ) and
the CDC to ensure that the proposed regulations were consistent with
other regulations, policies, and procedures currently in existence
surrounding this issue. We also met with them to gain information on
areas where we could mirror existing processes to eliminate undue
burdens on States or providers.
We issued a State survey to capture data from all related payment
policies regardless of whether they were implemented as a result of the
July 31, 2008 SMDL or whether such practices are currently detailed in
the State plan. We have received helpful information from a few States
through the survey and have reviewed other information that has been
helpful in explaining current State processes for making payment
adjustments for HCACs. Subsequent to the publication of the survey, we
held all-State calls where we answered questions in response to the
survey, had States with existing policies talk about their experiences,
and listened to discussion regarding the implementation of the HCAC
policy.
We met with nongovernmental partners including the NQF, the
National Academy for State Health Policy, the National Association of
Children's Hospitals, the Joint Commission, and State Medicaid Medical
Directors. Most of these organizations are primarily focused on State
program development and/or quality issues. We reached out to them to
ensure that the proposed policies were consistent with current industry
understanding of both State payment and quality improvement goals. In
our discussions with these organizations, we were able to discuss State
experiences on a broad, national level that had been gained from
working with States. During these meetings, we discussed a number of
issues related to the proposed rule and State concerns in implementing
this provision. For instance, it was clear from many of our discussions
that States hoped to be able to look to this provision to provide
additional definition regarding the types of conditions to identify for
nonpayment, as well as to provide some support in working with provider
communities to which these policies would be applied.
G. Current State Practices Prohibiting Payment for HACs, HCACs, and
Other Similar Events
We found that 29 States do not have existing HCAC-related
nonpayment policies. Most of the 21 States that currently have HCAC-
related nonpayment policies identify at least Medicare's HACs for
nonpayment in hospitals. However, it is important to note that at least
half of the existing policies we reviewed exceeded Medicare's current
HAC requirements and policies, either in the conditions identified, the
systems used to indicate the conditions, or the settings to which the
nonpayment policies applied. These policies vary tremendously from
State to State in the authority used to enact the policies, the
terminology used, the conditions identified, State's utilization of the
current Medicare HAC list, the service settings to which nonpayment
policies are applied, reporting requirements, and the claims processing
of the nonpayment policies.
All of the States with HCAC-related nonpayment policies have
implemented provisions that would protect the State from dual-eligible
liability either by directly prohibiting payment for Medicare crossover
claims or by relying on existing State plan authority to deny payment
for claims previously denied by Medicare.
We found that 17 of the States implemented Medicaid specific
policies that reduce payment for services provided to Medicaid
beneficiaries. Most of the States implementing Medicaid specific
policies identify at least Medicare's current list of HACs, and nearly
half of those States defined a list that was different from Medicare's
current list of HACs for nonpayment.
[[Page 32819]]
Similar variation exists in States' plan language identifying
Medicare's NCD for nonpayment ranging from mirroring Medicare to
completely breaking from Medicare. We do note, however, that the nature
of the NQF serious reportable events, like surgery on the wrong body
part, proper surgery wrong patient, and wrong surgery, is so severe
that States were likely to have relied on State coverage provisions and
appropriate care requirements to deny payment for these events.
We also found that States use different general terminology for
HCAC-related nonpayment policies even though many of the conditions
identified overlap, are from the same sources, and do not generally
vary in medical definition from one list to the other. For example, 3
States identify ``air embolism'' as a condition for nonpayment under
its plans with the condition understood to be consistently defined for
medical purposes. However, one State includes air embolisms on its list
of ``HACs''; another includes the same condition as a ``Serious Adverse
Event''; and the third includes it on a list of ``Medical Errors.''
We also found that at least 7 of the States with HCAC-related
nonpayment policies apply those policies to settings other than the
inpatient hospital setting required by Medicare, including both
physicians and ambulatory surgical centers.
Variation across States is not surprising given the States have
been permitted broad flexibility in defining their HCAC policies and
programs. However, we attribute some of the variety on this issue to
the wealth of information and evidence-based guidelines available to
States, either through their own experiences and resources or through
industry researched and developed resources related to health system
quality. Data gathered on the conditions identified, reporting
strategies, and implementation guidelines indicate that States have
relied heavily on existing health system quality improvement research
to define requirements while tailoring policies appropriate to their
own systems. In addition, our research indicates that States' HCAC-
related nonpayment policies are mainly intended to drive broader health
system agendas to promote quality outcomes. We believe the use of
evidence-based measures and the push for health system quality are an
appropriate foundation for the proposed regulation. We proposed to
implement Medicaid HCAC regulations that would provide some consistency
across health care payers (Medicare and Medicaid). At the same time, we
also proposed to accommodate State flexibility to design individual
HCAC policies for nonpayment, quality-related programs suitable for
their own Medicaid program and health marketplace to the extent such
policies go beyond Federally-established minimum standards. The July
31, 2008 SMDL (08-004) instructed States to submit SPAs to
enact nonpayment provisions. Thirteen States submitted SPAs to include
PPC related nonpayment provisions in their Medicaid State plans. Other
States that implemented these policies through some other authority
like State law or administrative procedures will be required to submit
new SPAs for review and work with CMS to ensure their policies,
effective July 1, 2011, are in line with the final provisions of this
rule.
H. Provider Preventable Conditions
The final rule includes the umbrella term, ``Provider-Preventable
Conditions (PPC)'' which is defined as two distinct categories, Health
Care-Acquired Conditions (HCAC) and Other Provider-Preventable
Conditions (OPPC).
Health Care Acquired Conditions:
Apply to Medicaid inpatient hospital settings; and
Are defined as the full list of Medicare's HAC, with the
exception of Deep Vein Thrombosis/Pulmonary Embolism following total
knee replacement or hip replacement in pediatric and obstetric
patients, as the minimum requirements for States' PPC non-payment
programs.
Other Provider-Preventable Conditions include the following:
Apply broadly to Medicaid inpatient and outpatient health
care settings where these events may occur;
Are defined to include at a minimum, the three Medicare
National Coverage Determinations (surgery on the wrong patient, wrong
surgery on a patient, and wrong site surgery);
Would allow States to expand to settings other than IH
with CMS approval by nature of identifying events that occur in other
settings; and
Would allow States to expand the conditions identified for
non-payment with CMS approval, based on criteria set forth in the
regulation.
The final rule requires that States revise Medicaid plans to comply
with this provision and mandates that States implement provider self
reporting through claims systems. The final rule protects beneficiary
access to care by eliminating States' ability to unduly impact
providers for the occurrence of conditions identified. The final rule
requires that:
No reduction in payment for a provider preventable
condition will be imposed on a provider when the condition defined as a
PPC for a particular patient existed prior to the initiation of
treatment for that patient by that provider.
Reductions in provider payment may be limited to the
extent that the identified provider-preventable conditions would
otherwise result in an increase in payment; and the State can
reasonably isolate for nonpayment the portion of the payment directly
related to treatment for, and related to, the provider-preventable
conditions.
While the Statutory effective date is July 1, 2011, CMS intends to
delay compliance action on these provisions until July 1, 2012.
We proposed to exercise our authority under sections 1902(a)(4),
1902(a)(19), and 1902(a)(30)(A) of the Act to provide for
identification of provider preventable conditions (PPCs) as an umbrella
term for hospital and nonhospital acquired conditions identified by the
State for nonpayment to ensure the high quality of Medicaid services.
These statutory provisions authorize requirements that States use
methods and procedures determined by the Secretary to be necessary for
the proper and efficient administration of the State plan, to provide
care and services in the best interests of beneficiaries, and to
provide for payment that is consistent with quality of care,
efficiency, and economy.
With the introduction of this term, we proposed to include two
categories of PPCs--HCACs and other provider-preventable conditions
(OPPCs). HCACs would apply as required under the statute. OPPCs would
be applicable to other conditions that States identify and have
approved through their Medicaid State plans.
The inclusion of the new terms, PPCs and OPPCs, is consistent with
the implementation of a broader application of this policy which allows
us to appropriately incorporate existing State practices. The adoption
of a new term is necessary because the term, ``health care-acquired
condition'' is very narrowly defined in the Statute and does not
provide for the inclusion of conditions other than those identified as
HACs for Medicare, even excludes the three Medicare NCDs. Additionally,
the Affordable Care Act definition of HCACs only applies to the
inpatient hospital setting.
We considered a broader definition of the term, ``health care-
acquired conditions,'' attempting to isolate the idea of the actual
condition from the setting in which it occurred. Section
[[Page 32820]]
1886(d)(4)(D)(iv) of the Act applies specifically to conditions
applicable to inpatient hospital patients and reimbursed under the
IPPS. We did look to the Affordable Care Act in creating the terms PPCs
and OPPCs.
We did look to the Affordable Care Act in creating the terms PPC
and OPPC. Section 3008(b) of the Affordable Care Act, ``Study And
Report On Expansion Of Healthcare Acquired Conditions Policy To Other
Providers,'' requires that Medicare study the effects of expanding its
existing policy to other providers. We adopted the ``Other Providers''
term to remain consistent with Medicare in the potential expansion of
its policy.
In looking to expand the overall policy, we considered a number of
other terms but determined that many of them like ``adverse events'' or
``serious reportable events'' would generate confusion because they had
existing industry definitions that did not necessarily overlap with our
policy aims. We adopted the term ``Provider Preventable Condition'' for
use in Medicaid because it appropriately identified the scope of the
conditions and could act as a ``catch-all.'' Also, the term had not
been narrowly defined by use in Medicare, Medicaid, or in the industry
at-large.
I. Reporting of Results
After researching State, industry, and Federal information related
to the importance of reporting of quality data in driving improved
health outcomes, we proposed that a simplified level of reporting is
essential to creating a successful nonpayment policy both from the
payment and quality perspectives. We believe that any requirements for
provider reporting should provide a consistent format for States to
report State-specific measures; require that providers report
conditions identified for nonpayment when they occur regardless of a
provider's intention to bill; and not cause undue burden on States or
providers.
Quality reporting related to PPCs across States is inconsistent.
There are 27 States that require reporting of either hospital-acquired
infections, conditions, or some combination of both. Some of those
States require quality reporting but have not implemented associated
HCAC-related nonpayment policies. Others have HCAC-related nonpayment
policies, but have not implemented quality reporting requirements.
Existing national quality reporting formats do not support the
collection of data on HCACs and OPPCs for Medicaid beneficiaries.
Providers, mainly hospitals, are subject to reporting requirements in
addition to those imposed by States. For instance, most hospitals
report some quality measures to CMS, the Joint Commission, or the CDC.
We considered requiring hospitals to report to CMS or the National
Health Safety Network, but decided against this because of concerns
about the capacity within these systems to accommodate State specific
reporting of varied measures and the fact that this might not be
consistent with what most States are currently requiring providers to
report.
HACs, HCACs, and related policies represent liabilities for
providers beyond nonpayment provisions. In fact, Medicare and the
industry-at-large, have experienced nonclaiming or nonbilling on the
part of providers seeking to escape the liability that could come with
any type of notification of a particular event or to avoid negative
health outcome indicators.
In consideration of our research, we proposed a requirement that
existing claims systems be used as a platform for provider self-
reporting. We also proposed to include reporting provisions that would
require provider reporting in instances when there is no associated
bill. For instance, States could employ the widely used POA system in
combination with including edits in their Medicaid claims systems that
would indicate an associated claim and flag it for medical review.
J. States' Use of Payment Systems Other Than MS-DRG
We also found that States' payment systems will dictate the manner
in which States are able to operationalize PPCs related nonpayment
policies. For instance, some States reimburse using MS-DRG or some
other type of grouper software to price claims. As with Medicare, these
States may use the POA indicator system to identify claims and reduce
payments by programming the grouper to reduce payment through the
grouper. We note that a considerable number of States do not use
grouper systems to reimburse providers. These States may identify and
reduce payment for HCACs using methods appropriate to the specific
reimbursement system used within that State. We believe that the
proposed provision allows States this type of flexibility in designing
methodologies that would isolate amounts for nonpayment and allow
provider payment to be reduced based on a CMS-approved State plan
methodology that is prospective in nature.
II. Summary of the Provisions of the Proposed Rule and Analysis of and
Responses to Public Comments
A. General Discussion
We proposed to codify provisions that would allow States
flexibility in identifying PPCs that include, at a minimum, the HACs
identified by Medicare, but may also include other State-identified
conditions. This flexibility will extend to applying nonpayment
provisions to service settings beyond the inpatient hospital setting.
We believe that establishing Medicare as the minimum for the
application of this policy is appropriate at this point.
We encouraged States to consider the benefits and quality
implications of expanding HCAC quality and nonpayment policies as more
information becomes available from Medicare and State Medicaid
programs.
We proposed that PPCs are defined under two categories: HCACs and
OPPCs. We proposed to define the category of PPCs that would be
referred to using the term ``health care-acquired conditions'' (HCACs)
based on the definition of that term in section 2702(b) of the
Affordable Care Act. We also noted that the Secretary has authority to
update the Medicare HAC list as appropriate. As such, States are
required to comply with subsequent updates or revisions in accordance
with section 1886(d)(4)(D) of the Act.
We proposed to require that States implement requirements for
provider self-reporting of HCACs in the Medicaid claims payment
process. We also proposed to provide that States may identify similar
OPPCs related to services furnished in settings other than inpatient
hospitals, which would also be subject to a payment prohibition.
We further proposed that the treatment of these OPPCs will be
similar to the treatment of HCACs. State plans must provide for
nonpayment for care and services related to these OPPCs, and Federal
financial participation (FFP) will not be available in State
expenditures for such care and services related to OPPCs.
We received the following comments in response to our general
discussion.
1. General Comments
Comment: One commenter expressed the view that the original
Medicare HAC policy adopted by CMS in FY 2008 for hospitals subject to
the Medicare Inpatient Prospective Payment System (IPPS hospitals), in
response to the requirements of the DRA, was flawed policy and that
many physicians disagreed with the notion that some of
[[Page 32821]]
the identified Medicare HACs are reasonably preventable. The commenter
was opposed to extending these provisions to Medicaid and suggested
that CMS abandon the notion of a nonpayment policy for HACs in both
Medicare and Medicaid and replace it with a policy encouraging
compliance with evidence-based guidelines.
Response: We disagree. The Medicare HAC payment policy was
established under the authority of section 5001(c) of the DRA and has
been in place since FY 2008. Section 2702 of the Affordable Care Act
requires that CMS adopt similar regulations for the Medicaid program
taking into consideration existing State practices and the appropriate
application to the Medicaid program. This regulation, like the Medicare
HAC rule that preceded it, was developed in direct response to the
enactment of that provision. While we recognize that some of the PPCs
are not entirely preventable and should therefore be excluded from the
program. However, most of these PPCs are never events, which means they
should never happen, in the first place, and they are entirely
preventable if providers follow best medical practices. This is true
regardless of whether a patient is a senior citizen on Medicare or a
child on Medicaid. PPCs that used to be regarded as not entirely
preventable, like CLABSI (or CAUTI), have been shown to be preventable
by providers. We believe that the provisions of this rule will provide
a strong incentive for the provider to apply best medical practice and
seek innovative methods to prevent adverse outcomes. The HACs were
adopted by Medicare through an evidence-based process. In addition, the
definition used for OPPC in new Sec. 447.26 provides that States must
consider evidence-based guidelines in adopting optional PPCs.
Comment: Some commenters supported the policy of payment adjustment
when conditions were demonstrated to be reasonably preventable based on
the evidence, but thought that the population differences between
Medicare and Medicaid may present distinct issues and considerations in
considering events for nonpayment. Some commenters questioned the
appropriateness of the application of Medicare HACs to Medicaid
populations, specifically children and pregnant women.
Response: We agree that Medicare's population is generally
different than Medicaid's and that those differences may present
distinct issues and considerations. We realize that some categories of
Medicare's HACs, like Surgical Site Infection following CABG or
Bariatric surgery, are not typically applicable to pediatric or
obstetric populations because the underlying conditions associated with
each of Medicare's HACs will not typically occur in those populations,
thus limiting the frequency and relevance of the HAC. We reviewed each
of Medicare's HACs and the related evidence-based prevention protocols
to determine whether the final rule should specifically exclude any of
the conditions identified by Medicare, with respect to populations more
characteristic of Medicaid, particularly children and pregnant women.
We considered each in relation to the following:
(1) Clinical applicability. That is, does this condition occur in
pediatric and obstetric populations enough to significantly impact the
populations or provider reimbursement?
(2) Availability of evidence based guidelines appropriate to
prevention for the pediatric and obstetric populations. Are there
bundles specific to preventing these conditions and infections in the
pediatric and obstetric populations? If bundles do not exist, are there
other bundles that can be appropriately applied to these populations?
(3) Reasonable preventability. Can the conditions or infections be
reasonably prevented through the use of evidence based guidelines to
warrant financial penalties? Our research determined that certain
Medicare HACs, such as Foreign Objects Retained After Surgery, Air
Embolism, Blood Incompatibility, Stage 3 and 4 Pressure Ulcers, Falls
and Trauma, and Manifestations of Poor Glycemic Control, Catheter
Associated Urinary Tract Infections, and Vascular-Catheter Associated
Blood Stream Infections, are clinically applicable to all Medicaid
populations, including children and pregnant women. We determined that
there are evidence-based guidelines to support the reasonable
preventability of these conditions in pediatric and obstetric
populations, and that there is no indication that these prevention
guidelines would cause harm if appropriately applied. There was no
evidence to indicate that a provider adhering to these evidence based
guidelines could not reasonably prevent, though not absolutely prevent
these infections in every case in Medicaid populations.
Our research determined that Surgical Site Infection following
CABG, Bariatric Surgery, or Orthopedic procedures is not typically
applicable to children and pregnant women because it is not likely that
these populations would be subject to some of the primary surgical
procedures. However, we determined that there are evidence-based
guidelines to support the reasonable preventability of Surgical Site
Infection following the specified procedures when they do occur in
these populations. Furthermore, there is no indication that these
prevention guidelines would cause harm when appropriately applied.
There is no evidence to indicate that a provider adhering to these
evidence based guidelines could not reasonably prevent, though not
absolutely prevent, these infections in every case in Medicaid
populations.
Our research also determined that the Medicare HAC Deep Vein
Thrombosis/Pulmonary Embolism (DVT/PE) as related to a total knee
replacement or hip replacement is not a common occurrence for children
or pregnant women because it is not likely that these populations would
be subject to the primary surgical procedures of total knee replacement
or hip replacement. We determined that evidence-based guidelines
available support the reasonable preventability of DVT/PE in most
cases, however, the related prevention protocols have not been proven
appropriate for application in children and pregnant women. Therefore,
we are not identifying the Medicare HAC, DVT/PE as related to total
knee replacement, or hip replacement for pediatric or obstetric
populations under Medicaid's PPC policy. We have revised the final rule
to reflect this determination.
We remind commenters that the Medicare HACs serve as a baseline,
and that States electing to expand their policies to consider other
conditions associated with children and pediatric quality measures may
do so through the SPA process. We encourage States to collaborate both
with CMS and other States, as well as their provider communities and
stakeholders like CDC and AHRQ to implement informed policies
appropriate to their Medicaid populations. We will support State
efforts and cross-educate, through the State plan amendment process and
by providing information that we gather from States and other programs.
Comment: One commenter believed that the expansion of PPCs for
Medicaid under the proposed rule goes beyond any previous guidance
shared by CMS with the State during Affordable Care Act-related
conference calls.
Response: Discussions held with the States, stakeholder groups and
various provider communities regarding this policy were necessary to
determine existing State practices regarding non-payment for health
care-acquired conditions. They were informational for
[[Page 32822]]
CMS and did not in any way commit the Secretary to a particular policy
direction. They were also a first effort in allowing States without
existing policies to gather some general information from and network
with States with existing policies.
The final regulation incorporates conditions identified as
Medicare's HACs, with the exception of DVT/PE as related to total knee
replacement and total hip replacement for pediatric and obstetric
populations, and 3 NCDs as the minimum requirement for State PPC
nonpayment policies. The rule allows States the flexibility, if
desired, but does not require, States to identify additional conditions
as PPCs under their Medicaid programs. Additionally, States have
already begun to develop PPC-related non-payment policies and this rule
would allow that work to continue.
Comment: A few commenters believed that there was not sufficient
time to implement these provisions for providers that had not already
been subject to Medicare's policy, and were particularly concerned with
the implementation timeframes for reporting.
Response: We anticipate that States and providers, especially those
groups of providers that have not been subject to Medicare's HAC
policy, will need to work collaboratively to develop policies and
implement reporting systems that would complement existing payment
structures. We believe given the timeframes involved and the need for
States to provide guidance to providers, it would be appropriate to
delay compliance action on the provisions of the rule until July 1,
2012.
Comment: One commenter requested that we strike Sec. 447.26(c)(4)
because they believed the access requirements proposed there were
already reflected in 447.204 which requires that payment be sufficient
to assure beneficiary access. The commenter thought that any dual
interpretations could lead to unwarranted litigation risks.
Response: We thank the commenter for this comment. We have revised
the language at 447.26(c)(4) to clarify that, ``A State plan must
ensure that non-payment for provider-preventable conditions does not
prevent access to services for Medicaid beneficiaries.''
2. Conditions Identified and Providers Affected
Comment: Some commenters pointed out that Medicare's HAC policy
applies only to Medicare IPPS hospitals. These commenters believed that
CMS should limit Medicaid PPC payment restrictions to Medicaid
participating hospitals that are similar to Medicare IPPS hospitals.
Other commenters asked for clarification on this same point. Most of
these commenters also believed that we should limit States ability to
identify other PPCs, proposing that the set of Medicare's HACs and 3
NCDs be used as a ceiling instead of as a floor for Medicaid's PPC
policy.
Response: The Affordable Care Act requires that HACs identified
under the Medicare IPPS are applicable to all entities that operate as
Medicaid inpatient hospitals. We do not have the authority to exempt
any Medicaid inpatient hospital providers from these requirements.
States currently have the authority to extend PPC-related non-payment
policies to other conditions.
Comment: Some commenters objected to the entire category of OPPC
(affecting providers other than hospitals) included in the proposed
regulation. Commenters recommended that CMS consider and impose a
number of parameters related to States' implementation and selection of
the OPPC category.
Response: In preparing this regulation, the Statute required that
CMS consider existing State practices and determine whether, as a
matter of policy, it was appropriate to include those established
practices in these final regulations. We determined that, in some
instances, States had implemented provisions that applied to providers
in settings other than inpatient hospital settings, including
outpatient hospital settings. We did not believe that it was prudent to
require of all States what had been done in a few, but we wanted to
provide States the flexibility to do so. Accordingly, we designed the
PPC provisions to allow the expansion of State policies to other care
settings, and other conditions. In light of the differences between the
types of participating providers and the enrollee populations in
Medicare and Medicaid, we provided flexibility for States in the
identification and application of OPPCs. We anticipate that States will
consider arguments made by particular providers that these OPPCs should
be defined so that they do not apply to them. We believe this is the
appropriate forum for consideration of the unique circumstances of
particular providers.
Comment: Some commenters recommended that we consider the benefits
of and establish a nationally consistent set of conditions identifiable
as PPCs for Medicaid.
Response: We determined that the conditions identified as
Medicare's HACs, with the exception of DVT/PE as related to total knee
replacement and total hip replacement for pediatric and obstetric
populations, and 3 NCDs are appropriate to serve as the baseline for
Medicaid's PPC policy. We are strongly committed to permitting State
flexibility to innovate in this area. State innovation has been a
significant driver of Federal policy, and States have direct experience
with utilization and claims review with respect to Medicaid services.
Comment: Some commenters suggested that the initial set of
conditions be more limited and targeted, and that they be expanded
incrementally over time.
Response: Section 2702(b) of the Affordable Care Act defines the
term ``health care-acquired condition'' as ``a medical condition for
which an individual was diagnosed that could be identified by a
secondary diagnostic code described in section 1886(d)(4)(D)(iv) of the
Act.'' The provision also allows the Secretary to exclude conditions
not appropriate for application in Medicaid. As such, the final
regulation incorporates conditions identified as Medicare's HACs, with
the exception of DVT/PE as related to total knee replacement and total
hip replacement for pediatric and obstetric populations, and 3 NCDs.
Additionally, we believe that the flexibility provided States in
developing additional PPCs, beyond those established as the floor in
the final rule, allow for the type of incremental expansion of this
policy that the commenters suggest.
Comment: Other commenters recommended that Medicaid PPCs focus on
conditions specific to the Medicaid population. A few commenters
offered that it would be ideal for CMS to evaluate other Medicaid
specific conditions that would apply specifically to pregnant women or
children.
Response: We believe that the flexibility provided States in the
final rule will facilitate the development of additional Medicaid
specific conditions to be identified for nonpayment. Some State
Medicaid programs with existing policies have identified conditions
specific to certain populations like Obstetrical Hemorrhage with
Transfusion, which is a condition specific to pregnant women. We
encourage States to follow CMS's example in identifying conditions by
working with provider communities and industry partners.
Comment: A few commenters suggested that CMS coordinate Federal
PPCs policies across agencies and with other organizations developing
quality measures specific to Medicaid populations.
Response: We are actively working to coordinate with other health
reform initiatives such as the pediatric core quality measures,
accountable care
[[Page 32823]]
organizations, and health insurance exchanges to develop coordinated
Federal policy in the area of Health System Quality. We continue to
collaborate with States, providers, and other stakeholders to inform
policy decisions related to this area.
Comment: Some commenters stated that any extension of PPC beyond
the hospital setting was premature, and emphasized that application of
PPC to other providers was not feasible because of the different
patient populations, payment structures and conditions that applied in
different environments. These commenters stated unique issues in
various provider settings including long-term care settings, dialysis
clinics, and skilled nursing facilities.
Response: We disagree with the point that the PPC provisions should
be limited to the hospital environment. This rule requires that States
adopt minimum requirements for each category of PPC. States have the
flexibility to identify additional OPPCs if desired, but there is no
requirement to do so. Many States have already identified conditions
beyond the minimum requirements in this final rule. We understand
clearly that the category of OPPCs would allow expansion beyond the
hospital environment and must be done in close consultation with
affected providers and limited to situations where a State has made a
finding that the condition could reasonably have been prevented in
ordinary cases. We have revised regulatory text to make clear that
these are State determinations that must be made based on State
findings that the condition is reasonably preventable using procedures
supported by evidence-based guidelines. The identification of PPCs in
settings other than the hospital setting makes sense because, from the
perspective of the patient, it matters very little whether a wrong site
surgery occurred in a hospital, an ambulatory surgery center, or in a
minor surgery done in the physician's office. Moreover, States have
already gone beyond the hospital setting in their individual PPC
policies. All that this Federal regulation adds is the HCAC category
which requires nonpayment for the full list of Medicare's HACs, with
the exception of Deep Vein Thrombosis/Pulmonary Embolism following
total knee replacement or hip replacement in pediatric and obstetric
patients and the OPPC category which requires the minimum mandatory
inclusion of what are now the three Medicare NCDs: Surgery on the wrong
patient, wrong surgery on a patient, and wrong site surgery. We are
simply replicating the mandatory provisions in the Medicare program,
and adding these to the existing State flexibility under Medicaid to
establish payment and quality standards.
We encourage States to collaborate both with CMS and other States,
as well as their provider communities and stakeholders like CDC and
AHRQ to implement informed policies appropriate to their Medicaid
populations. We will support State efforts and cross-educate, through
the SPA process and by providing information that we gather from States
and other programs.
Comment: A number of commenters requested that CMS clarify that the
HCAC category applies only to inpatient hospitals.
Response: This final rule has revised regulatory language to
clarify that the HCAC category applies to all inpatient hospital
settings under Medicaid. The OPPC category minimum requirements
(Medicare's 3 NCDs) are applicable in any healthcare service setting
where these events may occur.
Comment: One commenter expressed concern that expansion of PPC to
nonhospital providers threatened the access of Medicaid beneficiaries
to care. In particular, the commenter asked CMS to clarify that
Medicaid payment disallowance for PPC would not apply when the PPC was
present at the time the provider commenced treatment of the patient.
Response: The language in the proposed regulation was intended to
cover only situations where payment reduction was being applied to
treatment for a condition not present on admission or commencement of
treatment by that provider. However, we understand that clarifying the
language of the regulation to emphasize this point would be helpful and
have done so in this final regulation. New Sec. 447.26 (c)(2)
explicitly states that ``* * * no reduction in payment for a PPC will
be imposed on a provider when the condition defined as a PPC for a
particular patient existed prior to the initiation of treatment for
that patient by that provider.'' This was implied in the previous
language, but has now been made explicit. CMS agrees with the comment
and is providing this clarification.
CMS disagrees with the commenter's point that the expansion of
State PPC policies beyond the hospital environment will limit access.
We understand clearly that expansion beyond the hospital environment
must be done in close consultation with affected providers and limited
to situations where a provider could reasonably have prevented the PPC.
However, from the perspective of the patient, it matters very little
whether a wrong site surgery occurred in a hospital, an ambulatory
surgery center, or in a minor surgery done in the physician's office.
Moreover, as the commenter notes, States have already gone beyond the
hospital setting in their individual PPC policies.
Comment: One commenter requested that CMS provide States additional
guidance on applying the Medicare HAC criteria to Medicaid providers
and conditions. This commenter believed that we should partner with
States to have continued dialogue on evidence-based guidelines.
Response: As stated throughout the rule, we intend to continue
dialogue with States and other Agencies related to this issue.
3. PPC Terminology
Comment: A few commenters believed that the distinctions among the
terms in the proposed rule were confusing and made it difficult to
understand which term applied to which criteria.
Response: We have revised the regulatory text to clarify that PPCs
are clearly defined into two separate categories, HCACs (conditions
identified as Medicare's HACs (with the exception of DVT/PE following
total knee replacement or hip replacement in pediatric and obstetric
patients) for IPPS purposes, applied broadly to Medicaid inpatient
hospitals) and OPPCs (conditions applicable in any healthcare service
setting minimally defined as Medicare's 3 NCDs).
Comment: A few commenters objected to the use of the term PPC. One
proposed the use of the alternative term ``Preventable Healthcare
Related Conditions.'' The commenters noted that one proprietary
organization is currently utilizing the acronym PPC for ``Potentially
Preventable Conditions.''
The commenters also questioned our use of the term other provider
preventable condition and stated their biggest concern was with
creating a new term that encompassed 3 NCDs so closely related with the
NQF's ``Serious Reportable Events in Healthcare.'' The commenters
recommended that CMS not create explicit category titles under the PPC
umbrella term.
Response: As stated in the preamble, the designation of these terms
is necessary to a policy that meets statutory requirements in setting
Medicare's policy as the minimum and allowing States the flexibility to
expand beyond that minimum. We do not believe that the term PPC has
been
[[Page 32824]]
narrowly defined across the industry to include a specific set of
policy provisions as would be required by this final rule. In addition,
we do not believe that the use of the PPC acronym will infringe on any
proprietary organizations' ability to continue to use that acronym. We
have not made any revisions to this final rule to reflect this comment.
Comment: One commenter had questions regarding the definition of
OPPC. The commenter questioned which evidence-based guidelines would be
used and recommended that the regulation be expanded to include exact
definitions of the guidelines.
Response: It would be difficult to determine a singular set of
guidelines to be identified for the various conditions that States may
identify under these provisions. The rule provides States flexibility
in determining the conditions identified for nonpayment under their
individual State plans. As States submit plans for approval, we will
evaluate the conditions proposed by States and determine their
appropriateness for the Medicaid program. Additionally, we would remind
commenters that the Secretary has the authority to revisit these
provisions and may do so as this policy area develops. We reject the
commenters recommendation and have made no changes to the final
provisions regarding this issue.
Comment: Many commenters recommended that more research be done by
Medicare and Medicaid on applying PPC nonpayment policies to outpatient
settings before conditions that occur in those settings are
incorporated into PPC nonpayment policies or expanded. Some commenters
objected to the designation of the 3 NCDs as a baseline for the
Medicaid policy.
Response: Medicare is conducting additional research to inform its
policy on applying its HAC provisions beyond its IPPS hospitals. In
preparing this regulation, CMS was required to consider existing State
practices and determine whether, as a matter of policy, it was
appropriate to include those established practices in these final
regulations. We determined that, in some instances, States had
implemented provisions that applied to providers in settings other than
inpatient hospital settings, including outpatient hospital settings. We
did not believe that it was prudent to require of all States what had
been done in a few, but we wanted to provide States the flexibility to
do so. Accordingly, we designed the PPC provisions to allow the
expansion of State policies to other care settings, and other
conditions. We agree that States should do additional research to
evaluate the impact of applying nonpayment policies in outpatient
settings before adopting such policies. It should also be noted that
States with existing policies that do not meet the minimum provisions
of this final rule and those without existing policies will need to
submit for CMS approval SPAs implementing these policies.
The three events that we are requiring that States include in their
OPPC are those events which already trigger payment reductions in the
Medicare program as national coverage determinations (NCDs). In the
Medicare program, NCDs are already applied to all providers, not just
to specified hospitals. Medicare NCDs are detailed, evidence-based
determinations that are supported by substantial data. Therefore,
inclusion of these three events merely replicates evidence-based
determinations that are already in effect in the Medicare program.
Comment: One commenter stated that the expansion of State PPC
policies into non-inpatient settings will be extremely difficult to
implement due to the very characteristics that are inherent to the
outpatient setting, such as: The types of care and services provided;
numerous providers and provider-types involved in care; periodic
episodes of care provided by numerous providers over lengthy periods of
time; and lack of systems and infrastructure to adequately coordinate
care between visits and providers, among others. The wide variety of
payment systems create enormous challenges for provider reporting,
according to this commenter.
Response: We are encouraging States to work with provider
communities and other stakeholders to carefully examine nonpayment
policies in non-inpatient settings. Additionally, we are requiring that
States submit for approval Medicaid State plan amendments that would
implement PPC nonpayment policies. To support these Medicaid State plan
amendments, we are clarifying that the State must have made findings
that the proposed PPC is reasonably preventable through the application
of evidence-based guidelines. The SPA review process will give CMS and
providers the opportunity to consider State policy before it is
implemented and to provide guidance and input based on our knowledge of
the issues.
4. POA and Coding Systems
Comment: Several commenters objected to the burden of creating a
POA system and the potential for variation in the different State PPC
policies. Commenters are concerned that the POA requirement and its
impact on reimbursement may result in extraneous testing, delayed care,
and further access issues for Medicaid patients. In emergency
situations, it is often impossible to provide optimal patient care and
simultaneously determine POA status, it was noted. One commenter also
noted that many hospitals were not familiar with the intricacies of POA
coding and would require CMS guidance and time to implement it.
Response: The POA system is not required by this final regulation,
but obviously providers will need to carefully document the physical
status of their patients on admission. That documentation is not simply
done for legal purposes, but serves